<html xmlns="http://www.w3.org/1999/xhtml"> <head> <style type="text/css">
      	     		 
      	    a                          {background : #ffffff; }
      	    article                    {border-style : dotted; border-width : 2px; }
		 	
		 	div                        {background : #ffffcc;}
		 	div.abstract-title         {font-weight : bold ; font-size : 16pt;}
		 	div.ack                    {border-style : solid ; border-color : red; margin : 2em; }
		 	div.article-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.boxed-text             {margin : 5em; border-style : solid;}
		 	div.contrib-group          {margin : 1em; }
		 	div.fig                    {border-style : solid; border-width : 2px; margin : 2em; }
		 	div.funding                {font-weight : bold ; font-size : 16pt;}
		 	div.given-names            {font-style : italic;}
		 	div.intro                  {border-style : inset; margin : 5px;}
		 	div.introduction           {border-style : inset; margin : 5px;}
		 	div.journal-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.journal-title-group    {background : #ffeeee;}
		 	div.article-title          {font-weight : bold ; font-size : 18pt;}
		 	div.kwd                    {font-style : italic}
		 	div.meta-name              {font-weight : bold ; font-size : 16pt;}
		 	div.name                   {font-weight : bold;}
		 	div.alt-title              {font-style : italic; font-size : 12px;}
		 	
		 	div.sec                    {border : 2px; margin 5px; padding 2px;}
		 	div.title                  {font-family : courier; font-weight : bold;
		 	                            font-size : 16pt; margin : 5px;}
		 	
		 	div.materials_methods      {border-style : double; margin : 5px; }
		 	div.methods                {border-style : double; margin : 5px; }
		 	
		 	div.results                {border-style : solid; margin : 5px;}
		 	div.background             {border-style : dotted; margin : 5px;}
		 	
		 	div.discussion             {border-style : groove; margin : 5px;}
		 	div.conclusion             {border-style : ridge; margin : 5px;}
		 	div.conclusions             {border-style : ridge; margin : 5px;}
		 	div.supplementary-material {border-style : inset; margin : 5px;}
		 	div.abbreviations          {border-style : double; border-color : red; margin : 5px;}
		 	div.competinginterests     {border-style : double; border-color : blue; margin : 5px;}
		 	div.acknowledgements       {border-style : double; border-color : green; margin : 5px;}
		 	div.authors_contributions   {border-style : double; border-color : purple; margin : 5px;}
		 	
		 	div.publisher              {border-style : outset; margin : 5px;}
		 	div.fn-type-conflict       {background : #f88; }
		 	div.fn-type-con            {background : #ddf; }
		 	div.fn-type-other          {background : #ddd; }
		 	
		 	div.unknown                {background : #ffd;
									 	  border-style : solid;
									 	  border-width : 1px;
									 	  padding : 2 px;}
		 	  
      	    table                      {background : #ffffdd;}
		 	tr                         {background : #ddddff; padding : 1px;}
		 	
		 	span                       {background : #ffcccc;}
		 	
		 	span.citation-author       {font-family : helvetica; background : #ffeeee;}
		 	span.collab                {background : #ddffff; }
		 	span.comment               {font-family : courier; font-size : 6px; background : #ffaaff;}
		 	span.contrib               {background : #ffffff;}
		 	span.corresp               {background : #ddffdd; }
		 	span.doi                   {background : #ffffff;}
		 	span.email                 {font-family : courier; }
		 	span.etal                  {font-style : italic;}
		 	span.fpage                 {font-family : courier;}
		 	span.given-names           {background : #ffffff;}
		 	span.iso-abbrev            {background : #ffffff;}
		 	span.issn-epub             {background : #ffffff;}
		 	span.issn-ppub             {background : #ffffff;}
		 	span.journal-title         {background : #ffffff;}
		 	span.lpage                 {font-family : courier;}
		 	span.mixed-article-title   {font-style : italic ;}
		 	span.nlm-ta                {background : #ffffff;}
		 	span.pmc                   {background : #ffffff;}
		 	span.pmcid                 {background : #ffffff;}
		 	span.pmid                  {background : #ffffff;}
		 	span.publisher             {background : #ffffff;}
		 	span.publisher-id          {background : #ffffff;}
		 	span.publisher-name        {background : #ffffff;}
		 	span.source                {background : #ffffff;}
		 	span.subject               {background : #ffffff;}
		 	span.surname               {background : #ffffff;}
		 	span.volume                {font-family : courier; font-weight : bold;}
		 	span.year                  {font-family : courier ; font-style : italic;}
			</style> </head> <body> <div class="front" title="front"> <div class="journal-meta" tagx="journal-meta" title="journal-meta"><span class="nlm-ta" title="nlm-ta">J Biomol Struct Dyn</span><span class="iso-abbrev" title="iso-abbrev">J Biomol Struct Dyn</span><div class="journal-title-group" tagx="journal-title-group" title="journal-title-group"><span class="journal-title" tagx="journal-title" title="journal-title">Journal of Biomolecular Structure &amp;amp; Dynamics</span></div><span class="issn-ppub" tagx="issn" title="issn-ppub">0739-1102</span><span class="issn-epub" tagx="issn" title="issn-epub">1538-0254</span><div class="publisher" tagx="publisher" title="publisher"><span class="publisher-name" tagx="publisher-name" title="publisher-name">Taylor &amp;amp; Francis</span></div> </div> <div class="article-meta" tagx="article-meta" title="article-meta"><span class="pmcid" title="pmcid"> pmcid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/7738211">7738211</a></span><span class="pmid" title="pmid"> pmid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/33297848">33297848</a></span><span class="doi" title="doi"> doi: <a href="https://dx.doi.org/10.1080/07391102.2020.1850358">10.1080/07391102.2020.1850358</a></span><span class="publisher-id" title="publisher-id">1850358</span><div class="unknown" title="article-version" tag="article-version">
Version of Record</div> <div class="article-categories" title="article-categories">
: <span class="subject" title="subject">Research Article</span>: <span class="subject" title="subject">Research Article</span></div> <div class="title-group" tagx="title-group" title="title-group"> <div class="article-title" title="article-title"><i>In vitro</i> antimicrobial, physicochemical, pharmacokinetics and molecular docking studies of benzoyl uridine esters against SARS-CoV-2 main protease</div> <div class="alt-title" title="alt-title">
M. M. Matin et al.</div> <div class="alt-title" title="alt-title">
Journal of Biomolecular Structure and Dynamics</div> </div> <div class="contrib-group" title="contrib-group"><span class="contrib" title="contrib"><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0003-4965-2280</span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Matin</span><span class="given-names" tagx="given-names" title="given-names">Mohammed Mahbubul</span></span><a href="#AF0001">a</a><a href="#AN0001" /></span><span class="contrib" title="contrib"><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0002-6887-9344</span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Uzzaman</span><span class="given-names" tagx="given-names" title="given-names">Monir</span></span><a href="#AF0001">a</a><a href="#AF0002">b</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chowdhury</span><span class="given-names" tagx="given-names" title="given-names">Shagir Ahammad</span></span><a href="#AF0001">a</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bhuiyan</span><span class="given-names" tagx="given-names" title="given-names">Md. Mosharef Hossain</span></span><a href="#AF0001">a</a></span><span class="citation_author_institution" id="AF0001">[a], <span class="institution" title="institution">Bioorganic and Medicinal Chemistry Laboratory, Department of Chemistry, Faculty of Science, University of Chittagong</span><span class="city" tagx="city" title="city">Chattogram</span><span class="country" tagx="country" title="country">Bangladesh</span></span><span class="citation_author_institution" id="AF0002">[b], <span class="institution" title="institution">Faculty of Engineering, Department of Applied Chemistry and Biochemical Engineering, Shizuoka University</span><span class="city" tagx="city" title="city">Hamamatsu</span><span class="country" tagx="country" title="country">Japan</span></span></div> <div class="author-notes" title="author-notes"> <div class="corresp" title="corresp"><b>CONTACT</b> Mohammed Mahbubul Matin <span class="email" tagx="email" title="email">mahbubchem@cu.ac.bd</span><span class="institution" title="institution">Bioorganic and Medicinal Chemistry Laboratory, Department of Chemistry, Faculty of Science, University of Chittagong</span>, <span class="city" tagx="city" title="city">Chattogram</span><span class="postal-code" tagx="postal-code" title="postal-code">4331</span>, <span class="country" tagx="country" title="country">Bangladesh</span></div> </div><span class="pub-date-" title="pub-date-">: <span>2020-12-12</span></span><span class="pub-date-" title="pub-date-">: <span>2020</span></span><span class="fpage" tagx="fpage" title="fpage">1</span><span class="lpage" tagx="lpage" title="lpage">13</span><div class="permissions"><span class="copyright" title="copyright">(C) <span class="copyright-holder" tagx="copyright-holder" title="copyright-holder">Informa UK Limited, trading as Taylor &amp;amp; Francis Group</span>, <span class="copyright-year" tagx="copyright-year" title="copyright-year">2020</span></span><span class="license" title="license"><span class="license-p" title="license-p">This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.</span></span></div><a class="self-uri" href="TBSD_0_1850358.pdf" title="self-uri">TBSD_0_1850358.pdf</a><div class="abstract" title="abstract"> <div class="abstract-title" title="abstract-title">
Abstract</div> <div class="title" tagx="title" title="title">
Abstract</div> <p>Different esters were found potential against microorganisms, and could be a better choice to solve the multidrug resistant (MDR) pathogenic global issue due to their improved biological and pharmacokinetic properties. In this view, several 4-<i>t</i>-butylbenzoyl uridine esters <b>4â€"15</b> with different aliphatic and aromatic groups were synthesized for antimicrobial, physicochemical and biological studies. <i>In vitro</i> antimicrobial tests against nine bacteria and three fungi along with prediction of activity spectra for substances (PASS) indicated promising antifungal functionality of these uridine esters compared to the antibacterial activities. In support of this observation their cytotoxicity and molecular docking studies have been performed against lanosterol 14Î±-demethylase (CYP51A1) and <i>Aspergillus flavus</i> (1R51). Significant binding affinities were observed against SARS-CoV-2 main protease (7BQY) considering hydroxychloroquine (HCQ) as standard. ADMET predictions were investigated to evaluate their absorption, metabolism and toxic properties. Most of the uridine esters showed better results than that of the HCQ. Overall, the present study might be useful for the development of uridine-based novel MDR antimicrobial and COVID-19 drugs.</p> </div> <div class="abstract" title="abstract"> <div class="title" tagx="title" title="title">
Graphical Abstract</div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/" /></div>  </div> <p>Communicated by Ramaswamy H. Sarma</p> </div> <div class="kwd-group"> <div class="title" tagx="title" title="title">
Keywords</div> <div class="kwd" title="kwd">
Uridine esters</div> <div class="kwd" title="kwd">
density functional theory</div> <div class="kwd" title="kwd">
thermodynamic and orbital properties</div> <div class="kwd" title="kwd">
antimicrobial activities</div> <div class="kwd" title="kwd">
PASS and ADMET predications</div> <div class="kwd" title="kwd">
SARS-CoV-2 main protease</div> </div> <div class="counts" title="counts"><span class="fig-count" title="fig-count">fig-count: </span><span class="table-count" title="table-count">table-count: </span><span class="page-count" title="page-count">page-count: </span><span class="word-count" title="word-count">word-count: </span></div> </div> </div> <div class="body" title="body"> <div class="introduction" title="sec"><span class="label" tagx="label" title="label">1.</span><div class="title" tagx="title" title="title">
Introduction</div> <p>Uridine (<b>1</b>), a natural and necessary nucleoside, is one of the four basic components of ribonucleic acid (RNA). It is a structural element of many bioactive compounds, and it has crucial role in the pyrimidine metabolism of the brain. Uridine and its nucleotide derivatives may also have an additional role in the function of the central nervous system as signaling molecules (Dobolyi et al., <a href="#CIT0008">2011</a>). It has anti depression activity, asthmatic airway inflammation, hepatocyte proliferation (Carlezon et al., <a href="#CIT0003">2005</a>). Uridine has sleep-promoting and anti-epileptic effects, might affect mood, improves memory function and influences neuronal plasticity (Siegel et al., 2017). Uridine, sometimes, has been recognized as playing a role in preserving and enhancing hepatic mitochondrial function in the face of challenge by certain liver toxins (Banasch et al., <a href="#CIT0002">2006</a>). In addition, uridine (<b>1</b>) and some of its biological derivatives behave as antimetabolites, when their extracellular concentrations are higher than those physiological levels (Strasser et al., 2006; Yamamoto et al., <a href="#CIT0046">2011</a>).</p> <p>Many advantageous findings were reported for the uridine derivatives especially its esters. For example, uridine 5â€² esters showed neuroprotective effect and is capable of compensating the harmful effect of neurotoxins with the increase the 5-HT and 5-HIAA levels (Susilo, 2008). 3â€²,4â€²-Uridine acetonide (<b>2</b>, <a href="#F0001">Figure 1</a>) showed a differential effect and a higher activity over cell viability on MCF-7 human cancer breast cell line than for the CHO-K1 cell line (Escober et al., <a href="#CIT0010">2016</a>). Some uridine esters were found to exhibit promising antimicrobial properties (Kabir, Matin, &amp;amp; Kawsar, <a href="#CIT0015">1998</a>; Kabir, Matin, Kawsar, &amp;amp; Anwar, <a href="#CIT0016">1998</a>; Kabir, Matin, Mridha, et al., <a href="#CIT0017">1998</a>; Kabir et al., <a href="#CIT0018">1998a</a>, <a href="#CIT0015">1998</a>b) such as 3â€²-<i>O</i>-decanoyl-2â€²,5â€²-di-<i>O</i>-acetyluridine (<b>3</b>) was found very active against <i>E. coli</i> (Kabir et al., <a href="#CIT0013">2002</a>). Thus, it has been proven that the uridine derivatives especially acyl esters can be used as drugs in order to treat, for instance, Parkinson, Alzheimer, Chorea Huntington or depression with cellular regulatory functions (Escober et al., <a href="#CIT0010">2016</a>).</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 1.</span></a></div>   <p>Structures of <b>1</b>â€"<b>4</b>.</p>   </div> <p>Although uridine analogues (e.g. doxifluridine) have shown higher activities in the treatment of viral and cancer treatment, their efficiency is sometimes reduced by the appearance of resistance mechanisms (De Clercq, <a href="#CIT0007">2011</a>). Hence, search for newer analogues of uridine (nucleoside) got more attention especially esterification of its sugar moiety (Du et al., <a href="#CIT0009">2018</a>). However, investigations indicated that selective esterification (acylation) uridine (<b>1</b>) creates difficulties due to the presence of one 1Â° OH group, two 2Â° OH groups and a NH group. Hence, various methods like direct acylation (Matin, Bhattacharjee, et al., <a href="#CIT0028">2019</a>; Matin, Bhuiyan, et al., <a href="#CIT0032">2019</a>; Matin, Chakraborty, et al., <a href="#CIT0033">2020</a>; Matin, Hasan, et al., <a href="#CIT0034">2020</a>; Matin, Roshid, et al., <a href="#CIT0037">2020</a>), dibutyltin oxide (DBTO) method (Kabir, Matin, &amp;amp; Kawsar, <a href="#CIT0015">1998</a>; Kabir, Matin, Kawsar, &amp;amp; Anwar, <a href="#CIT0016">1998</a>; Kabir, Matin, Mridha, et al., <a href="#CIT0017">1998</a>; Kabir et al., <a href="#CIT0014">1997</a>, <a href="#CIT0018">1998a</a>, <a href="#CIT0015">1998</a>b), coupling technique (Steglich esterification) (Clayden et al., <a href="#CIT0005">2012</a>), protectionâ€"deprotection (Matin et al., <a href="#CIT0029">2017</a>) and enzymatic method (Du et al., <a href="#CIT0009">2018</a>) were reported. Among these methods, direct method generally furnished 5â€²-<i>O</i>-substituted esters (Kabir, Matin, &amp;amp; Kawsar, <a href="#CIT0015">1998</a>; Kabir, Matin, Kawsar, &amp;amp; Anwar, <a href="#CIT0016">1998</a>; Kabir, Matin, Mridha, et al., <a href="#CIT0017">1998</a>; Kabir et al., <a href="#CIT0014">1997</a>, <a href="#CIT0018">1998a</a>, <a href="#CIT0015">1998</a>b) whereas DBTOmethod gave 3â€²-<i>O</i>-substituted products (Kabir, Matin, &amp;amp; Kawsar, <a href="#CIT0015">1998</a>; Kabir, Matin, Kawsar, &amp;amp; Anwar, <a href="#CIT0016">1998</a>; Kabir, Matin, Mridha, et al., <a href="#CIT0017">1998</a>; Kabir et al., <a href="#CIT0014">1997</a>, <a href="#CIT0018">1998a</a>, <a href="#CIT0015">1998</a>b, <a href="#CIT0013">2002</a>). However, in most of the cases direct method gave higher yield(s) with lower cost (Matin, <a href="#CIT0027">2014</a>; Matin et al., <a href="#CIT0029">2017</a>). Chowdhury et al. (<a href="#CIT0004">2016</a>) applied direct method with hindered 4-<i>t</i>-butylbenzoyl chloride in pyridine at âˆ’5â€‰Â°C and afforded the 5â€²-<i>O</i>-(4-<i>t</i>-butylbenzoyl)uridine (<b>4</b>) in excellent yield.</p> <p>Now-a-days, emergence of multiple drug resistant (MDR) pathogenic organisms, and corona virus disease 2019 (COVID-19) are global concern (Ghosh et al., <a href="#CIT0011">2020</a>; Lakshmi et al., <a href="#CIT0021">2020</a>; Wahedi et al., <a href="#CIT0045">2020</a>) in addition to numerous obstacles encountered on delivery to the site of microbial infection. Many researchers are engaged to overcome these situations (Awual, <a href="#CIT0001">2017</a>; Laws et al., <a href="#CIT0022">2020</a>; Matin, <a href="#CIT0026">2008</a>; Sharavanan et al., <a href="#CIT0041">2020</a>). However, there is urgent need for establishment of new chemotherapeutic agents with novel mode of action to combat with these MDR organisms, and SARS CoV-2 (severe acute respiratory syndrome corona virus-2). In this regard as well as our continuous effort to find novel drugs (Matin, <a href="#CIT0027">2014</a>; Matin &amp;amp; Ibrahim, <a href="#CIT0035">2010</a>; Matin et al., <a href="#CIT0031">2015</a>) we report herein the <i>in vitro</i> antimicrobial efficacy of several uridine-based esters <b>4</b>â€"<b>15</b> with different aliphatic and aromatic chains against eleven pathogens, molecular docking against lanosterol 14Î±-demethylase (3LD6), <i>A. flavus</i> (1R51) and corona virus (SARS CoV-2) main protease (Mpro; 7BQY) along with prediction of activity spectra for substances (PASS). Also, attempts have been taken to optimize some acylated uridine derivatives to investigate their physicochemical behavior on the basis of DFT approach with cytotoxicity, and ADMET properties.</p> </div> <div class="materialandmethods" title="sec"><span class="label" tagx="label" title="label">2.</span><div class="title" tagx="title" title="title">
Material and methods</div> <div class="materials:uridineesters4â€" title="sec"><span class="label" tagx="label" title="label">2.1.</span><div class="title" tagx="title" title="title">
Materials: uridine esters 4â€"15</div> <p>In our present study, twelve uridine-based esters with different side chain length and different groups <b>4</b>â€"<b>15</b> were used as test chemicals. These compounds (mainly 5â€²-<i>O</i>-<i>t</i>-butylbenzoyl esters of uridine), as presented in <a href="#F0002">Figure 2</a>, were synthesized from <b>1</b> by direct method and well characterized earlier (Chowdhury et al., <a href="#CIT0004">2016</a>). For comparative study, uridine (<b>1</b>), standard antibacterial antibiotic ampicillin and antifungal antibiotic nystatin were also used.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 2.</span></a></div>   <p>Structures of <b>4</b>â€"<b>15</b>.</p>   </div> </div> <div class="passpredication" title="sec"><span class="label" tagx="label" title="label">2.2.</span><div class="title" tagx="title" title="title">
Pass predication</div> <p>Web-based PASS (<a href="http://www.pharmaexpert.ru/">http://www.pharmaexpert.ru/</a> PASSonline/index.php) was used for the prediction of biological spectrum of these uridine derivatives (Matin et al., <a href="#CIT0036">2016</a>). Initially, structures of the uridine esters were drawn, and then, converted into their SD file formats which were used to predict biological spectrum using PASS online software. This program is designed to anticipate a plethora of biological activities with 90% accuracy. PASS results are designated as Pa (probability for active compound) and Pi (probability for inactive compound). Being probabilities, the Pa and Pi values vary from 0.000 to 1.000 and in general, Paâ€‰+â€‰Pi â‰ 1, since these probabilities are calculated independently. Only the activities with Paâ€‰&amp;gt;â€‰Pi are considered as possible for a particular drug. The PASS prediction results were interpreted and used in a flexible manner, viz. (i) when Pa &amp;gt; 0.7, the chance to find the activity experimentally is high, (ii) if 0.5 &amp;lt; Pa &amp;lt; 0.7, the chance to find the activity experimentally is less, but the compound is probably not so similar to known pharmaceutical agents and (iii) if Pa &amp;lt; 0.5, the chance to find the activity experimentally is less, but the chance to find a structurally. So, the predicted activity of spectrum of a drug is known as its intrinsic property.</p> </div> <div class="2.3.invitroantimicrobialactivitytest" title="sec"> <div class="title" tagx="title" title="title"><i>2.3.</i> In vitro <i>antimicrobial activity test</i></div> <div class="testorganisms" title="sec"><span class="label" tagx="label" title="label">2.3.1.</span><div class="title" tagx="title" title="title">
Test organisms</div> <p>The tested microorganisms (bacteria and fungi) were collected from the Pharmacology laboratory, Department of Physiology, Biochemistry &amp;amp; Pharmacology, Faculty of Veterinary Medicine, Chittagong Veterinary and Animal Science University, Chattogram, Bangladesh. As shown in <a href="#t0001">Table 1</a>, nine human pathogenic bacteria and three plant pathogenic fungi were used for the antimicrobial evaluation.</p> <div class="table-wrap_UNKNOWN" id="t0001" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 1.</span> <p>Name of the pathogenic microorganisms.</p>  <table frame="hsides" rules="groups"> <colgroup> <col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup>  <thead> <tr> <th align="left">Sl.</th> <th align="center">Strain</th> <th colspan="2" align="center">Reference</th> <th align="center">Source</th> </tr> </thead> <tbody valign="top"> <tr> <td colspan="2">Gram-positive bacteria</td> <td colspan="2">Â </td> <td align="left">Â </td> </tr> <tr> <td align="left">(i)</td> <td align="left"><i>Bacillus cereus</i></td> <td colspan="2">BTCC 19</td> <td align="left">Gastrointestinal tract</td> </tr> <tr> <td align="left">(ii)</td> <td align="left"><i>Bacillus megaterium</i></td> <td colspan="2">BTCC 18</td> <td align="left">Clinical strains</td> </tr> <tr> <td align="left">(iii)</td> <td align="left"><i>Bacillus subtilis</i></td> <td colspan="2">BTCC 17</td> <td align="left">Gastrointestinal tract</td> </tr> <tr> <td align="left">(iv)</td> <td align="left"><i>Staphylococcus aureus</i></td> <td colspan="2">ATCC 6538</td> <td align="left">Dairy cows</td> </tr> <tr> <td colspan="5">Gram-negative bacteria</td> </tr> <tr> <td align="left">(v)</td> <td align="left"><i>Escherichia coli</i></td> <td colspan="2">ATCC 25922</td> <td align="left">Clinical isolate</td> </tr> <tr> <td align="left">(vi)</td> <td align="left"><i>Shigella dysenteriae</i></td> <td colspan="2">AE 14369</td> <td align="left">Milk &amp;amp; dairy products</td> </tr> <tr> <td align="left">(vii)</td> <td align="left"><i>Salmonella paratyphi</i></td> <td colspan="2">ATCC 11511</td> <td align="left">Clinical isolate</td> </tr> <tr> <td align="left">(viii)</td> <td align="left"><i>Salmonella typhi</i></td> <td colspan="2">AE 14612</td> <td align="left">Raw meat</td> </tr> <tr> <td align="left">(ix)</td> <td align="left"><i>Vibrio cholera</i></td> <td colspan="2">ICDDR, B</td> <td align="left">Stool sample</td> </tr> <tr> <td colspan="3">Name of the fungi</td> <td colspan="2">Type of organism</td> </tr> <tr> <td align="left">(i)</td> <td colspan="2"><i>Aspergillus acheraccus</i></td> <td colspan="2">Human pathogenic</td> </tr> <tr> <td align="left">(ii)</td> <td colspan="2"><i>Aspergillus flavus</i></td> <td colspan="2">Human pathogenic</td> </tr> <tr> <td align="left">(iii)</td> <td colspan="2"><i>Macrophomina phaseolina</i></td> <td colspan="2">Human pathogenic</td> </tr> </tbody> </table> </div> </div> <div class="screeningofantibacterialactivity" title="sec"><span class="label" tagx="label" title="label">2.3.2.</span><div class="title" tagx="title" title="title">
Screening of antibacterial activity</div> <p><i>In vitro</i> antibacterial activities of uridine <b>4</b>â€"<b>15</b> were conducted by paper disc diffusion method (Kabir et al., <a href="#CIT0012">2003</a>; Matin et al., <a href="#CIT0030">2013</a>), which was determined by the presence or absence of diameter of zone of inhibition (in mm). In this method, initially a 2% solution of the uridine compound(s) in DMF was prepared. Mueller-Hinton (agar and broth) medium was used to culture the bacteria. Paper disc of 4â€‰mm in a diameter and petri plate of 70â€‰mm in a diameter was used throughout the experiment. These paper discs were sterilized in an autoclave and dried at 150â€‰Â°C in an electric oven. Then, the discs were socked with test compound(s) at the rate of 100â€‰Î¼g (dry weight) per disc. These paper discs were put in the petri-plates and were incubated at 37â€‰Â°C for 48â€‰h for growth of test organisms followed by the cooling for 4â€‰h at low temperature (4â€‰Â°C). The test chemicals diffused from disc to the surrounding medium by this time. The growth inhibition was calculated at 24â€‰h intervals for two days. Each experiment was carried out three times. All the results were compared with the standard antibacterial antibiotic ampicillin (50â€‰Î¼g/disc, brand name Decapen, Beximco Pharmaceuticals Ltd., Bangladesh). Ampicillin was also used as a positive control and proper control was maintained with DMF without chemicals under identical conditions.</p> </div> <div class="screeningofmycelialgrowth" title="sec"><span class="label" tagx="label" title="label">2.3.3.</span><div class="title" tagx="title" title="title">
Screening of mycelial growth</div> <p>The <i>in vitro</i> antifungal screening of the synthesized uridine derivatives (<b>4</b>â€"<b>15</b>) were investigated employing food poisoning technique (Kabir, Matin, &amp;amp; Kawsar, <a href="#CIT0015">1998</a>; Kabir, Matin, Kawsar, &amp;amp; Anwar, <a href="#CIT0016">1998</a>; Kabir, Matin, Mridha, et al., <a href="#CIT0017">1998</a>; Kabir et al., <a href="#CIT0018">1998a</a>, <a href="#CIT0015">1998</a>b; Matin, <a href="#CIT0027">2014</a>). Sabouraud potato dextrose agar (PDA, agar and broth) medium was used for the culture of fungi. Necessary amount of medium was taken in a conical flask separately and was sterilized in an autoclave (at 121â€‰Â°C and 15â€‰psi) for 15â€‰min. After autoclaving, weighed amount of test chemical (2% in DMF) was added to the sterilized medium in conical flask at the point of pouring to obtain desired concentration. The flask was shaken thoroughly to mix the chemical with the medium homogeneously before pouring. The medium with definite concentration (2%) of chemical was poured at the rate of 100â€‰Î¼g/mL PDA in sterilized glass petri dishes individually and subjected for incubation. Finally, linear mycelial growth of fungus was measured after 2â€"5â€‰days (24â€‰h interval) of incubation. The percentage of radial mycelial growth inhibition of the test fungus was calculated using the following equation: </p><div class="disp-formula" title="disp-formula"> <div class="alternatives" title="alternatives"> <div class="graphic" position="float" orientation="portrait" /><div class="math_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mi_UNKNOWN">
I</div> <div class="mo_UNKNOWN">
=</div> <div class="mrow_UNKNOWN"> <div class="mo_UNKNOWN">
{</div> <div class="mrow_UNKNOWN"> <div class="mfrac_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mo_UNKNOWN">
(</div> <div class="mrow_UNKNOWN"> <div class="mi_UNKNOWN">
C</div> <div class="mo_UNKNOWN">
âˆ’</div> <div class="mi_UNKNOWN">
T</div> </div> <div class="mo_UNKNOWN">
)</div> </div> </div> <div class="mi_UNKNOWN">
C</div> </div> </div> <div class="mo_UNKNOWN">
}</div> </div> <div class="mo_UNKNOWN">
Ã—</div> <div class="mn_UNKNOWN">
100</div> </div></div></div> </div> <p /> <p>Where, <i>I</i> = percentage of inhibition, <i>C</i> = diameter of the fungal colony in control (DMF), <i>T</i> = diameter of the fungal colony in treatment. In all the cases, the results were compared with standard antifungal antibiotic nystatin (100â€‰Î¼g/mL medium, brand name Fungistin, Beximco Pharmaceuticals Ltd., Bangladesh). Proper control was maintained separately and with sterilized PDA medium without chemical and three replications were prepared for each treatment.</p> </div> </div> <div class="computationaldetails:dft" title="sec"><span class="label" tagx="label" title="label">2.4.</span><div class="title" tagx="title" title="title">
Computational details: DFT</div> <p>Quantum mechanical (QM) methods has gained attention on calculation of thermodynamic properties, molecular orbital features, dipole moment and as well as interpretation of different types of interactions. Molecular geometry optimization and further modification of all uridine derivatives carried out using Gaussian 16 program. All the structures were optimized using density functional theory (DFT) employing Beckeâ€™s (B) three-parameter hybrid model, Lee, Yang and Parrâ€™s (LYP) correlation functional under 3-21G basis set (Kruse et al., <a href="#CIT0020">2012</a>). Initial optimization of all compounds was performed in the gas phase. Dipole moment, electronic energy, enthalpy and free energy are calculated for all the compounds.</p> <p>Frontier molecular orbital features HOMO (highest occupied molecular orbital), LUMO (lowest unoccupied molecular orbital) were calculated at the same level of theory. For each of the structure HOMO-LUMO gap(Î"<i>Îµ</i>), hardness (<i>Î·</i>), softness (<i>S</i>) and chemical potential (<i>Âµ</i>) were calculated from the energies of frontier HOMO and LUMO as reported considering Parr and Pearson interpretation of DFT and Koopmans theorem (Pearson, <a href="#CIT0039">1986</a>) on the correlation of ionization potential and electron affinities with HOMO and LUMO energy (<i>Îµ</i>). Hardness (<i>Î·</i>), softness (<i>S</i>) and chemical potential (<i>Âµ</i>) are calculated by using the following equations: </p><div class="disp-formula" title="disp-formula"> <div class="alternatives" title="alternatives"> <div class="graphic" position="float" orientation="portrait" /><div class="math_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mtext_UNKNOWN">
Gap</div> <div class="mi_UNKNOWN" /> <div class="mrow_UNKNOWN"> <div class="mo_UNKNOWN">
(</div> <div class="mrow_UNKNOWN"> <div class="mo_UNKNOWN">
Î"</div> <div class="mi_UNKNOWN">
Îµ</div> </div> <div class="mo_UNKNOWN">
)</div> </div> <div class="mi_UNKNOWN" /> <div class="mo_UNKNOWN">
=</div> <div class="mi_UNKNOWN" /> <div class="mrow_UNKNOWN"> <div class="mo_UNKNOWN">
(</div> <div class="mrow_UNKNOWN"> <div class="mi_UNKNOWN">
Îµ</div> <div class="mtext_UNKNOWN">
LUMO</div> <div class="mi_UNKNOWN" /> <div class="mo_UNKNOWN">
â€"</div> <div class="mi_UNKNOWN" /> <div class="mi_UNKNOWN">
Îµ</div> <div class="mtext_UNKNOWN">
HOMO</div> </div> <div class="mo_UNKNOWN">
)</div> </div> <div class="mo_UNKNOWN">
;</div> <div class="mi_UNKNOWN" /> <div class="mi_UNKNOWN">
Î·</div> <div class="mi_UNKNOWN" /> <div class="mo_UNKNOWN">
=</div> <div class="mi_UNKNOWN" /> <div class="mrow_UNKNOWN"> <div class="mo_UNKNOWN">
(</div> <div class="mrow_UNKNOWN"> <div class="mi_UNKNOWN">
Îµ</div> <div class="mtext_UNKNOWN">
LUMO</div> <div class="mi_UNKNOWN" /> <div class="mo_UNKNOWN">
â€"</div> <div class="mi_UNKNOWN" /> <div class="mi_UNKNOWN">
Îµ</div> <div class="mtext_UNKNOWN">
HOMO</div> </div> <div class="mo_UNKNOWN">
)</div> </div> <div class="mo_UNKNOWN">
/</div> <div class="mn_UNKNOWN">
2</div> <div class="mo_UNKNOWN">
;</div> <div class="mtext_UNKNOWN">
 S </div> <div class="mo_UNKNOWN">
=</div> <div class="mi_UNKNOWN" /> <div class="mn_UNKNOWN">
1</div> <div class="mo_UNKNOWN">
/</div> <div class="mi_UNKNOWN">
Î·</div> <div class="mo_UNKNOWN">
;</div> <div class="mi_UNKNOWN" /> <div class="mi_UNKNOWN">
Î¼</div> <div class="mi_UNKNOWN" /> <div class="mo_UNKNOWN">
=</div> <div class="mi_UNKNOWN" /> <div class="mrow_UNKNOWN"> <div class="mo_UNKNOWN">
(</div> <div class="mrow_UNKNOWN"> <div class="mi_UNKNOWN">
Îµ</div> <div class="mtext_UNKNOWN">
LUMO</div> <div class="mi_UNKNOWN" /> <div class="mo_UNKNOWN">
+</div> <div class="mi_UNKNOWN" /> <div class="mi_UNKNOWN">
Îµ</div> <div class="mtext_UNKNOWN">
HOMO</div> </div> <div class="mo_UNKNOWN">
)</div> </div> <div class="mo_UNKNOWN">
/</div> <div class="mn_UNKNOWN">
2</div> </div></div></div> </div> <p /> <div class="proteinpreparationandvisualization" title="sec"><span class="label" tagx="label" title="label">2.4.1.</span><div class="title" tagx="title" title="title">
Protein preparation and visualization</div> <p>The 3D crystal structure of main protease of COVID-19 (7BQY), lanosterol 14Î±-demethylase (3LD6/CYP51A1) and <i>A. flavus</i> (1R51) was obtained in pdb format from online protein data bank (PDB) database (Lucido et al., <a href="#CIT0025">2016</a>). All hetero atoms, inhibitors and water molecules were erased using PyMol (version 1.3) software packages. Energy minimization of the protein implemented by Swiss-Pdb viewer software (version 4.1.0) (Matin, Chakraborty, et al., <a href="#CIT0033">2020</a>; Matin, Hasan, et al., <a href="#CIT0034">2020</a>; Matin, Roshid, et al., <a href="#CIT0037">2020</a>). The optimized structures were subjected for molecular docking study against 7BQY, CYP51A1 and 1R51 considering the protein as macromolecule and uridine esters as ligand. Finally, rigid docking simulation was performed by PyRx software (version 0.8) targeting the active site with the center grid box size 48.8375, 65.6838, 59.1841â€‰Ã… for 7BQY; 61.8544, 61.1656, 70.6697â€‰Ã… for 3LD6; and 58.4699, 69.9558, 58.3507â€‰Ã… for 15R1 along <i>x</i>, <i>y</i> and <i>z</i> directions, respectively. After docking, Accelrys Discovery Studio (version 4.1) software was utilized to analyze and visualize the docking results (Wahedi et al., <a href="#CIT0045">2020</a>). Docking results are basically calculated as binding affinities of ligand-protease and reported in kcal/mol unit.</p> </div> </div> <div class="toxicactivitytest" title="sec"><span class="label" tagx="label" title="label">2.5.</span><div class="title" tagx="title" title="title">
Toxic activity test</div> <p>For the determination of toxicity of the uridine derivatives we employed brine shrimp lethality assay technique as described by McLaughlin (<a href="#CIT0038">1991</a>). The tested compounds were dissolved in DMSO, and prepared 20, 40, 80 and 160â€‰Î¼L by adding NaCl solution to each vial up to 1â€‰mL volume which were designated as type- A, B, C and D, respectively. Three sets of experiment were done for each concentration and 10 brine shrimps nauplii were placed in each vial. A control experiment was performed in a vial containing 10 nauplii in 1â€‰mL seawater. After 24â€‰h and 48â€‰h of incubation at room temperature, the vials were observed using a magnifying glass and the number of survivors in each vial was counted and noted. From the data, the average percentage of mortality of nauplii was calculated for each concentration. No deaths were found for controls.</p> </div> <div class="admetcalculation" title="sec"><span class="label" tagx="label" title="label">2.6.</span><div class="title" tagx="title" title="title">
ADMET calculation</div> <p>Online computational approaches were made to predict absorption, distribution, metabolism, excretion and toxicity (ADMET) for 5â€²-<i>O</i>-(4-<i>t</i>-butylbenzoyl)uridine (<b>4</b>) and its 2â€²,3â€²-di-<i>O</i>-acyl derivatives <b>5</b>â€"<b>15</b> (Matin, Chakraborty, et al., <a href="#CIT0033">2020</a>; Matin, Hasan, et al., <a href="#CIT0034">2020</a>; Matin, Roshid, et al., <a href="#CIT0037">2020</a>). The computational prediction of drug could avoid the tremendous cost and time associated with the <i>in vivo</i> experiments, and has attracted more and more attention. In the present study, we utilized <i>in silico</i> screening approaches employing pkCSM server (<a href="http://biosig.unimelb.edu.au">http://biosig.unimelb.edu.au</a>). The pkCSM signatures were successfully used across five main different pharmacokinetic property classes to develop predictive regression and classification models (Pires et al., <a href="#CIT0040">2015</a>). Firstly, all the structures of uridine esters were drawn in ChemDraw 16.0 to collect InChI Key, isomeric SMILES (simplified molecular-input line-entry system), and SD file format. ADMET of all the uridine esters were predicted by using pkCSM-pharmacokinetics and SwissADME free web tools (<a href="http://www.swissadme.ch">http://www.swissadme.ch</a>).</p> </div> </div> <div class="resultsanddiscussion" title="sec"><span class="label" tagx="label" title="label">3.</span><div class="title" tagx="title" title="title">
Results and discussion</div> <p>In the present study, twelve uridine esters with different aliphatic and aromatic chains (<b>4â€"15</b>) were selected as test compounds, and screened for their <i>in vitro</i> antibacterial and antifungal activities against nine bacteria and, and three phytopathogenic fungi, respectively. Initially, we predicted these activities using PASS program followed by <i>in vitro</i> determination. The observed activities were then rationalized by calculating their physicochemical (DFT method), cytotoxicity (shrimp), molecular docking and ADMET properties. Finally, all these findings were used to summarize their structureâ€"activity relationship (SAR).</p> <div class="computational-basedbiologicalactivities:pass" title="sec"><span class="label" tagx="label" title="label">3.1.</span><div class="title" tagx="title" title="title">
Computational-based biological activities: PASS</div> <p>Having all the uridine esters <b>4</b>â€"<b>15</b>, we predicted their biological spectrum using online PASS software (<a href="http://www.pharmaexpert.ru/">http://www.pharmaexpert.ru/</a> PASSonline/index.php). The PASS results in its designated as Pa and Pi form is presented in <a href="#t0002">Table 2</a>.</p> <div class="table-wrap_UNKNOWN" id="t0002" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 2.</span> <p>Predicted biological activity of the uridine-based esters <b>4</b>â€"<b>15</b> using PASS software.</p>  <table frame="hsides" rules="groups"> <colgroup> <col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup>  <thead> <tr> <th rowspan="3" align="left">Drug</th> <th colspan="8" align="center">Biological activity <hr /> </th> </tr> <tr> <th colspan="2" align="center">Antibacterial <hr /> </th> <th colspan="2" align="center">Antifungal <hr /> </th> <th colspan="2" align="center">Anti-carcinogenic <hr /> </th> <th colspan="2" align="center">Antioxidant <hr /> </th> </tr> <tr> <th align="center">Pa</th> <th align="center">Pi</th> <th align="center">Pa</th> <th align="center">Pi</th> <th align="center">Pa</th> <th align="center">Pi</th> <th align="center">Pa</th> <th align="center">Pi</th> </tr> </thead> <tbody valign="top"> <tr> <td align="left"><b>1</b></td> <td align="center">0.397</td> <td align="center">0.031</td> <td align="center">0.421</td> <td align="center">0.046</td> <td align="center">0.785</td> <td align="center">0.006</td> <td align="center">â€"</td> <td align="center">â€"</td> </tr> <tr> <td align="left"><b>4</b></td> <td align="center">0.320</td> <td align="center">0.053</td> <td align="center">0.437</td> <td align="center">0.042</td> <td align="center">0.667</td> <td align="center">0.010</td> <td align="center">0.168</td> <td align="center">0.081</td> </tr> <tr> <td align="left"><b>5</b></td> <td align="center">0.348</td> <td align="center">0.044</td> <td align="center">0.486</td> <td align="center">0.033</td> <td align="center">0.668</td> <td align="center">0.010</td> <td align="center">0.156</td> <td align="center">0.095</td> </tr> <tr> <td align="left"><b>6</b></td> <td align="center">0.180</td> <td align="center">0.137</td> <td align="center">â€"</td> <td align="center">â€"</td> <td align="center">0.407</td> <td align="center">0.030</td> <td align="center">â€"</td> <td align="center">â€"</td> </tr> <tr> <td align="left"><b>7</b></td> <td align="center">0.327</td> <td align="center">0.050</td> <td align="center">0.526</td> <td align="center">0.027</td> <td align="center">0.621</td> <td align="center">0.012</td> <td align="center">0.158</td> <td align="center">0.093</td> </tr> <tr> <td align="left"><b>8</b></td> <td align="center">0.327</td> <td align="center">0.050</td> <td align="center">0.526</td> <td align="center">0.027</td> <td align="center">0.621</td> <td align="center">0.012</td> <td align="center">0.158</td> <td align="center">0.093</td> </tr> <tr> <td align="left"><b>9</b></td> <td align="center">0.327</td> <td align="center">0.050</td> <td align="center">0.526</td> <td align="center">0.027</td> <td align="center">0.621</td> <td align="center">0.012</td> <td align="center">0.158</td> <td align="center">0.093</td> </tr> <tr> <td align="left"><b>10</b></td> <td align="center">0.327</td> <td align="center">0.050</td> <td align="center">0.526</td> <td align="center">0.027</td> <td align="center">0.621</td> <td align="center">0.012</td> <td align="center">0.158</td> <td align="center">0.093</td> </tr> <tr> <td align="left"><b>11</b></td> <td align="center">0.327</td> <td align="center">0.050</td> <td align="center">0.526</td> <td align="center">0.027</td> <td align="center">0.621</td> <td align="center">0.012</td> <td align="center">0.158</td> <td align="center">0.093</td> </tr> <tr> <td align="left"><b>12</b></td> <td align="center">0.327</td> <td align="center">0.050</td> <td align="center">0.526</td> <td align="center">0.027</td> <td align="center">0.621</td> <td align="center">0.012</td> <td align="center">0.158</td> <td align="center">0.093</td> </tr> <tr> <td align="left"><b>13</b></td> <td align="center">0.193</td> <td align="center">0.125</td> <td align="center">0.436</td> <td align="center">0.042</td> <td align="center">0.482</td> <td align="center">0.021</td> <td align="center">â€"</td> <td align="center">â€"</td> </tr> <tr> <td align="left"><b>14</b></td> <td align="center">0.213</td> <td align="center">0.106</td> <td align="center">0.441</td> <td align="center">0.041</td> <td align="center">0.515</td> <td align="center">0.018</td> <td align="center">0.132</td> <td align="center">0.124</td> </tr> <tr> <td align="left"><b>15</b></td> <td align="center">0.163</td> <td align="center">0.152</td> <td align="center">0.389</td> <td align="center">0.052</td> <td align="center">0.467</td> <td align="center">0.022</td> <td align="center">0.431</td> <td align="center">0.10</td> </tr> <tr> <td align="left"><b>APC</b></td> <td align="center">0.750</td> <td align="center">0.003</td> <td align="center">â€"</td> <td align="center">â€"</td> <td align="center">â€"</td> <td align="center">â€"</td> <td align="center">â€"</td> <td align="center">â€"</td> </tr> <tr> <td align="left"><b>NYS</b></td> <td align="center">0.967</td> <td align="center">0.00</td> <td align="center">0.986</td> <td align="center">0.00</td> <td align="center">0.416</td> <td align="center">0.028</td> <td align="center">0.145</td> <td align="center">0.108</td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p>Pa: probability â€˜to be activeâ€™; Pi: probability â€˜to be inactiveâ€™; APC: ampicillin; NYS: nystatin.</p> </div> </div> </div> <p>It was evident from predication <a href="#t0002">Table 2</a> for uridine esters <b>4</b>â€"<b>15</b> showed 0.16 &amp;lt; Pa &amp;lt; 0.35 for antibacterial and 0.38 &amp;lt; Pa &amp;lt; 0.53 for antifungal. This clearly indicated that these compounds were more prone against fungi as compared to that of bacterial pathogens. Also, incorporation of mesyl groups, as in compound <b>6</b>, totally abolished antifungal potentiality of uridine. Addition of aliphatic acyl chains (C2 to C16, compound <b>5</b>, <b>7</b>â€"<b>12</b>) increased antifungal activity (Pa = 0.526) of uridine (<b>1</b>, Pa = 0.421), whereas attachment of chloro-substituted benzoyl groups did not enhance reasonably (<b>13</b>â€"<b>15</b>, Pa = 0.389â€"0.436). We have also calculated anti-carcinogenic and antioxidant property of these compounds. Thus, PASS predication showed 0.46 &amp;lt; Pa &amp;lt; 0.67 for anti-carcinogenic and 0.13 &amp;lt; Pa &amp;lt; 0.43 for antioxidant, which indicated that the uridine esters were more potent as anti-carcinogenic agents than that of antioxidant properties. Interestingly, the results as shown in <a href="#t0002">Table 2</a>, antifungal and anti-carcinogenic properties of uridine esters with saturated aliphatic chains (<b>5</b>, <b>7</b>â€"<b>12</b>) were found more promising than the sulphonyl ester (<b>6</b>) or chloro-substituted benzoyl derivatives (<b>13</b>â€"<b>15</b>). These results are in agreement with our previous study for monosaccharide esters (Matin, Chakraborty, et al., <a href="#CIT0033">2020</a>; Matin, Hasan, et al., <a href="#CIT0034">2020</a>; Matin, Roshid, et al., <a href="#CIT0037">2020</a>).</p> </div> <div class="3.2.invitroantimicrobialactivities" title="sec"> <div class="title" tagx="title" title="title"><i>3.2.</i> In vitro <i>antimicrobial activities</i></div> <div class="antibacterialpotentialityof4â€" title="sec"><span class="label" tagx="label" title="label">3.2.1.</span><div class="title" tagx="title" title="title">
Antibacterial potentiality of <b>4</b>â€"<b>15</b></div> <p>For the <i>in vitro</i> antibacterial efficacy test we followed disc diffusion method (Kabir et al., <a href="#CIT0012">2003</a>). The results of diameter of inhibition zone (mm) of the uridine-based esters <b>4</b>â€"<b>15</b> against four Gram-positive, and five Gram-negative bacteria are presented in <a href="#t0003">Table 3</a> (<a href="#F0003">Figure 3</a>) and <a href="#t0004">Table 4</a> (<a href="#F0004">Figure 4</a>). It was evident that these esters are less susceptible towards both the Gram-positive and Gram-negative pathogens, and similar results were reported for other uridine esters (Kabir, Matin, &amp;amp; Kawsar, <a href="#CIT0015">1998</a>; Kabir, Matin, Kawsar, &amp;amp; Anwar, <a href="#CIT0016">1998</a>; Kabir, Matin, Mridha, et al., <a href="#CIT0017">1998</a>; Kabir et al., <a href="#CIT0018">1998a</a>, <a href="#CIT0015">1998</a>b). Amongst the uridine derivatives, compound <b>8</b> (C6 chain) and <b>10</b> (C12 chain) showed moderate inhibition against <i>B. megaterium</i>, <i>S. dysenteriae</i> and <i>V. cholerae</i>. Also, mesyl derivative <b>6</b> and chlorobenzoyl derivatives <b>13</b>â€"<b>15</b> showed very little antibacterial functionality which is in agreement with the PASS results (<a href="#t0002">Table 2</a>). In general, compounds <b>4</b>â€"<b>15</b> were found more prone against Gram-negative pathogens than the Gram-positive organisms.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 3.</span></a></div>   <p>(a) Inhibition against Gram-positive bacteria; (b) Zone of inhibition observed against <i>Bacillus Cereus</i> by four test chemicals <b>13</b> (SO-10), <b>14</b> (K-7) and <b>15</b> (U-6).</p>   </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 4.</span></a></div>   <p>Inhibition against Gram-negative pathogens.</p>   </div> <div class="table-wrap_UNKNOWN" id="t0003" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 3.</span> <p>Inhibition against Gram-positive pathogens by uridine esters.</p>  <table frame="hsides" rules="groups"> <colgroup> <col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup>  <thead> <tr> <th rowspan="2" align="left">Drug</th> <th colspan="4" align="center">Diameter of zone of inhibition in mm (100 Âµg dw / disc) <hr /> </th> </tr> <tr> <th align="center"><i>B. cereus</i></th> <th align="center"><i>B. megaterium</i></th> <th align="center"><i>B. subtilis</i></th> <th align="center"><i>S. aureus</i></th> </tr> </thead> <tbody valign="top"> <tr> <td align="left"><b>1</b></td> <td align="center">13.6â€‰Â±â€‰0.39</td> <td align="center">8.5â€‰Â±â€‰0.50</td> <td align="center">7.5â€‰Â±â€‰0.50</td> <td align="center">NI</td> </tr> <tr> <td align="left"><b>4</b></td> <td align="center">NI</td> <td align="center">6.1â€‰Â±â€‰0.28</td> <td align="center">10.3â€‰Â±â€‰0.58</td> <td align="center">9.0â€‰Â±â€‰0.34</td> </tr> <tr> <td align="left"><b>5</b></td> <td align="center">NI</td> <td align="center">7.4â€‰Â±â€‰0.44</td> <td align="center">NI</td> <td align="center">NI</td> </tr> <tr> <td align="left"><b>6</b></td> <td align="center">NI</td> <td align="center">6.6â€‰Â±â€‰0.33</td> <td align="center">NI</td> <td align="center">NI</td> </tr> <tr> <td align="left"><b>7</b></td> <td align="center">NI</td> <td align="center">NI</td> <td align="center">NI</td> <td align="center">NI</td> </tr> <tr> <td align="left"><b>8</b></td> <td align="center">NI</td> <td align="center">10.3â€‰Â±â€‰0.38</td> <td align="center">NI</td> <td align="center">NI</td> </tr> <tr> <td align="left"><b>9</b></td> <td align="center">NI</td> <td align="center">9.1â€‰Â±â€‰0.50</td> <td align="center">NI</td> <td align="center">8.5â€‰Â±â€‰0.58</td> </tr> <tr> <td align="left"><b>10</b></td> <td align="center">NI</td> <td align="center">12.0â€‰Â±â€‰0.33</td> <td align="center">NI</td> <td align="center">NI</td> </tr> <tr> <td align="left"><b>11</b></td> <td align="center">NI</td> <td align="center">7.0â€‰Â±â€‰0.33</td> <td align="center">NI</td> <td align="center">NI</td> </tr> <tr> <td align="left"><b>12</b></td> <td align="center">NI</td> <td align="center">NI</td> <td align="center">NI</td> <td align="center">NI</td> </tr> <tr> <td align="left"><b>13</b></td> <td align="center">NI</td> <td align="center">NI</td> <td align="center">7.0â€‰Â±â€‰0.66</td> <td align="center">NI</td> </tr> <tr> <td align="left"><b>14</b></td> <td align="center">NI</td> <td align="center">6.6â€‰Â±â€‰0.33</td> <td align="center">NI</td> <td align="center">6.5â€‰Â±â€‰0.45</td> </tr> <tr> <td align="left"><b>15</b></td> <td align="center">NI</td> <td align="center">NI</td> <td align="center">NI</td> <td align="center">NI</td> </tr> <tr> <td align="left">**<b>AMP</b></td> <td align="center">*18.0â€‰Â±â€‰0.51</td> <td align="center">*16.1â€‰Â±â€‰0.64</td> <td align="center">*19.0â€‰Â±â€‰0.58</td> <td align="center">*22.2â€‰Â±â€‰0.24</td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p>Data are presented as (Mean Â± <i>SD</i>).</p> </div> <div class="fn-type-" title=""> <p>*Significantly inhibition values.</p> </div> <div class="fn-type-" title=""> <p>**Reference antibiotic ampicillin (AMP; 50â€‰Âµg/disc).</p> </div> <div class="fn-type-" title=""> <p>dw: dry weight; NI: no inhibition; NI was observed for control DMF; Values are represented for the triplicate of all the experiments.</p> </div> </div> </div> <div class="table-wrap_UNKNOWN" id="t0004" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 4.</span> <p>Inhibition against Gram-negative pathogens by <b>4</b>â€"<b>15</b>.</p>  <table frame="hsides" rules="groups"> <colgroup> <col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup>  <thead> <tr> <th rowspan="2" align="left">Drug</th> <th colspan="5" align="center">Diameter of zone of inhibition in mm (100 Âµg dw/disc) <hr /> </th> </tr> <tr> <th align="center"><i>E. coli</i></th> <th align="center"><i>S. dysenteriae</i></th> <th align="center"><i>S. paratyphi</i></th> <th align="center"><i>S. typhi</i></th> <th align="center"><i>V. cholerae</i></th> </tr> </thead> <tbody valign="top"> <tr> <td align="left"><b>1</b></td> <td align="center">8.6â€‰Â±â€‰0.50</td> <td align="center">NI</td> <td align="center">NI</td> <td align="center">10.5â€‰Â±â€‰0.50</td> <td align="center">NI</td> </tr> <tr> <td align="left"><b>4</b></td> <td align="center">7.5â€‰Â±â€‰0.44</td> <td align="center">NI</td> <td align="center">8.0â€‰Â±â€‰0.24</td> <td align="center">*12.5â€‰Â±â€‰0.50</td> <td align="center">5.0â€‰Â±â€‰0.44</td> </tr> <tr> <td align="left"><b>5</b></td> <td align="center">NI</td> <td align="center">6.0â€‰Â±â€‰0.58</td> <td align="center">NI</td> <td align="center">NI</td> <td align="center">NI</td> </tr> <tr> <td align="left"><b>6</b></td> <td align="center">NI</td> <td align="center">8.4â€‰Â±â€‰0.33</td> <td align="center">NI</td> <td align="center">NI</td> <td align="center">6.1â€‰Â±â€‰0.33</td> </tr> <tr> <td align="left"><b>7</b></td> <td align="center">NI</td> <td align="center">NI</td> <td align="center">NI</td> <td align="center">NI</td> <td align="center">6.6â€‰Â±â€‰0.33</td> </tr> <tr> <td align="left"><b>8</b></td> <td align="center">NI</td> <td align="center">*13.8â€‰Â±â€‰0.38</td> <td align="center">*12.8â€‰Â±â€‰0.83</td> <td align="center">NI</td> <td align="center">8.2â€‰Â±â€‰0.54</td> </tr> <tr> <td align="left"><b>9</b></td> <td align="center">9.5â€‰Â±â€‰0.50</td> <td align="center">6.7â€‰Â±â€‰0.71</td> <td align="center">7.8â€‰Â±â€‰0.58</td> <td align="center">NI</td> <td align="center">NI</td> </tr> <tr> <td align="left"><b>10</b></td> <td align="center">11.5â€‰Â±â€‰0.50</td> <td align="center">7.0â€‰Â±â€‰0.33</td> <td align="center">8.0â€‰Â±â€‰0.33</td> <td align="center">NI</td> <td align="center">*12.5â€‰Â±â€‰0.50</td> </tr> <tr> <td align="left"><b>11</b></td> <td align="center">NI</td> <td align="center">9.8â€‰Â±â€‰0.68</td> <td align="center">NI</td> <td align="center">NI</td> <td align="center">9.0â€‰Â±â€‰0.50</td> </tr> <tr> <td align="left"><b>12</b></td> <td align="center">7.7â€‰Â±â€‰0.64</td> <td align="center">NI</td> <td align="center">NI</td> <td align="center">NI</td> <td align="center">NI</td> </tr> <tr> <td align="left"><b>13</b></td> <td align="center">9.0â€‰Â±â€‰0.71</td> <td align="center">10.1â€‰Â±â€‰0.64</td> <td align="center">NI</td> <td align="center">NI</td> <td align="center">10.3â€‰Â±â€‰0.71</td> </tr> <tr> <td align="left"><b>14</b></td> <td align="center">NI</td> <td align="center">NI</td> <td align="center">NI</td> <td align="center">NI</td> <td align="center">7.0â€‰Â±â€‰0.48</td> </tr> <tr> <td align="left"><b>15</b></td> <td align="center">NI</td> <td align="center">NI</td> <td align="center">NI</td> <td align="center">NI</td> <td align="center">NI</td> </tr> <tr> <td align="left">**<b>AMP</b></td> <td align="center">*10.9â€‰Â±â€‰0.49</td> <td align="center">*22.1â€‰Â±â€‰0.68</td> <td align="center">*18.0â€‰Â±â€‰0.58</td> <td align="center">*20.2â€‰Â±â€‰0.24</td> <td align="center">*31.9â€‰Â±â€‰0.74</td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p>Data are presented as (Mean Â± <i>SD</i>).</p> </div> <div class="fn-type-" title=""> <p>*Significantly inhibition values.</p> </div> <div class="fn-type-" title=""> <p>**Reference antibiotic ampicillin (AMP; 50â€‰Âµg/disc).</p> </div> <div class="fn-type-" title=""> <p>dw: dry weight; NI: no inhibition; NI was observed for control DMF; Values are represented for the triplicate of all the experiments.</p> </div> </div> </div> <div class="table-wrap_UNKNOWN" id="t0005" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 5.</span> <p>Inhibition against fungal pathogens by <b>4</b>â€"<b>15</b>.</p>  <table frame="hsides" rules="groups"> <colgroup> <col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup>  <thead> <tr> <th rowspan="2" align="left">Drug</th> <th colspan="3" align="center">% Inhibition of fungal mycelial growth (100 Âµg dw/mL PDA) <hr /> </th> </tr> <tr> <th align="center"><i>A. acheraccus</i></th> <th align="center"><i>A. flavus</i></th> <th align="center"><i>M. phaseolina</i></th> </tr> </thead> <tbody valign="top"> <tr> <td align="left"><b>1</b></td> <td align="center">NI</td> <td align="center">NI</td> <td align="center">25.3â€‰Â±â€‰0.28</td> </tr> <tr> <td align="left"><b>4</b></td> <td align="center">6.9â€‰Â±â€‰0.24</td> <td align="center">NI</td> <td align="center">38.4â€‰Â±â€‰0.38</td> </tr> <tr> <td align="left"><b>5</b></td> <td align="center">18.7â€‰Â±â€‰0.64</td> <td align="center">NI</td> <td align="center">*57.8â€‰Â±â€‰0.64</td> </tr> <tr> <td align="left"><b>6</b></td> <td align="center">17.5â€‰Â±â€‰0.54</td> <td align="center">NI</td> <td align="center">NI</td> </tr> <tr> <td align="left"><b>7</b></td> <td align="center">19.0â€‰Â±â€‰0.24</td> <td align="center">NI</td> <td align="center">52.3â€‰Â±â€‰0.64</td> </tr> <tr> <td align="left"><b>8</b></td> <td align="center">NI</td> <td align="center">34.2â€‰Â±â€‰0.64</td> <td align="center">*58.1â€‰Â±â€‰0.50</td> </tr> <tr> <td align="left"><b>9</b></td> <td align="center">10.7â€‰Â±â€‰0.44</td> <td align="center">15.2â€‰Â±â€‰0.84</td> <td align="center">NI</td> </tr> <tr> <td align="left"><b>10</b></td> <td align="center">34.3â€‰Â±â€‰0.48</td> <td align="center">25.8â€‰Â±â€‰0.28</td> <td align="center">*69.2â€‰Â±â€‰0.50</td> </tr> <tr> <td align="left"><b>11</b></td> <td align="center">NI</td> <td align="center">28.0â€‰Â±â€‰0.50</td> <td align="center">48.0â€‰Â±â€‰0.84</td> </tr> <tr> <td align="left"><b>12</b></td> <td align="center">14.0â€‰Â±â€‰0.29</td> <td align="center">NI</td> <td align="center">41.0â€‰Â±â€‰0.54</td> </tr> <tr> <td align="left"><b>13</b></td> <td align="center">8.0â€‰Â±â€‰0.24</td> <td align="center">NI</td> <td align="center">46.1â€‰Â±â€‰0.83</td> </tr> <tr> <td align="left"><b>14</b></td> <td align="center">9.1â€‰Â±â€‰0.64</td> <td align="center">5.5â€‰Â±â€‰0.33</td> <td align="center">*72.0â€‰Â±â€‰0.68</td> </tr> <tr> <td align="left"><b>15</b></td> <td align="center">NI</td> <td align="center">NI</td> <td align="center">*73.1â€‰Â±â€‰0.84</td> </tr> <tr> <td align="left">**NYS</td> <td align="center">22.0â€‰Â±â€‰0.25</td> <td align="center">26.1â€‰Â±â€‰0.29</td> <td align="center">*71.8â€‰Â±â€‰0.58</td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p>Data are presented as (Mean Â± <i>SD</i>).</p> </div> <div class="fn-type-" title=""> <p>*Significant inhibition.</p> </div> <div class="fn-type-" title=""> <p>**Reference antibiotic nystatin NYS, 100â€‰Âµg/mL PDA.</p> </div> <div class="fn-type-" title=""> <p>dw: dry weight; NI: no inhibition; NI was observed for control DMF; Values are represented for the triplicate of all the experiments.</p> </div> </div> </div> </div> <div class="antifungalsusceptibilityof4â€" title="sec"><span class="label" tagx="label" title="label">3.2.2.</span><div class="title" tagx="title" title="title">
Antifungal susceptibility of 4â€"15</div> <p>The susceptibility of uridine esters <b>4</b>â€"<b>15</b> against three pathogenic fungi are presented in <a href="#t0004">Table 5</a>. The results, as presented in percentage inhibitions of mycelial growth, indicated that these compounds were more prone against tested fungal pathogens compared to bacterial organisms. Among the tested fungi, <b>4</b>â€"<b>15</b> were more susceptible against <i>M. phaseolina</i>. Aliphatic chain containing compound <b>5</b> (C2, 57.8%, <a href="#F0005">Figure 5</a>), <b>8</b> (C6, 58.1%) and <b>10</b> (C12, 69.2%) exhibited very good percentage of inhibition against this fungus. To our surprise, chlorobenzoyl ester <b>14</b> (*72%) and <b>15</b> (*73.1%) showed excellent inhibition against <i>M. phaseolina</i> and the results were comparable to nystatin (*71.8%) in contrast to their antibacterial and PASS results.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 5.</span></a></div>   <p>(a) Fungal inhibition by the uridine esters; (b) % Inhibition of mycelial growth of <i>A. acheraccus</i> by the <b>5</b> (U-7).</p>   </div> </div> </div> <div class="thermodynamicanalysis" title="sec"><span class="label" tagx="label" title="label">3.3.</span><div class="title" tagx="title" title="title">
Thermodynamic analysis</div> <p>The molecular structure significantly influences the structural properties such as free energy (<i>G</i>), enthalpy (<i>H</i>), dipole moment and electrostatic potential. Spontaneity of a reaction and stability of a product can be predicted from Gibbâ€™s free energy, enthalpy and electronic energy. Free energy (<i>G</i>) is a significant criterion to represent the interaction of binding partners, where negative value favorable for spontaneous binding and interaction. Greater negative values predict better thermodynamic properties. In the present study, all the uridine esters possess greater negative value for <i>E</i>, <i>H</i> and <i>G</i> than the parent uridine, and hence, indicated that the attachment of ester group could improve interaction and binding of these molecules with different microbial enzymes. Due to these higher values (â€"2990 to â€"3903 Hartree) chlorobenzoyl esters <b>14</b>â€"<b>15</b> exhibited better inhibition against <i>M. phaseolina</i>. In addition, these increased negative values of compound <b>4â€"15</b> suggested that these are energetically and configurationally more stable.</p> <p>As shown in <a href="#t0005">Table 6</a>, some of the uridine esters have improved dipole moment. Improved dipole moment enhances the polar nature of a molecule, and promotes the binding affinity, hydrogen bonding and nonbonding interaction with the receptor protein (Lien et al., <a href="#CIT0023">1982</a>). The dipole moment of compound <b>4</b> was 7.588 Debye and for compound <b>15</b> was 7.619 Debye which were slightly higher than the uridine (7.339 Debye) resulting their better binding affinity and interactions with the amino acid residues of receptor protein.</p> <div class="table-wrap_UNKNOWN" id="t0006" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 6.</span> <p>Molecular formula, molecular weight, electronic energy (<i>E</i>), enthalpy (<i>H</i>), Gibbâ€™s free energy (<i>G</i>) in Hartree and dipole moment (<i>Âµ</i>, Debye) of uridine derivatives.</p>  <table frame="hsides" rules="groups"> <colgroup> <col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup>  <thead> <tr> <th align="left">Drug</th> <th align="center">MF</th> <th align="center">MW</th> <th align="center"><i>E</i></th> <th align="center"><i>H</i></th> <th align="center"><i>G</i></th> <th align="center"><i>Î¼</i></th> </tr> </thead> <tbody valign="top"> <tr> <td align="left"><b>1</b></td> <td align="left">C<sub>9</sub>H<sub>12</sub>N<sub>2</sub>O<sub>6</sub></td> <td align="left">244.201</td> <td align="left">â€"900.579</td> <td align="left">â€"900.578</td> <td align="left">â€"900.635</td> <td align="char" char=".">7.339</td> </tr> <tr> <td align="left"><b>4</b></td> <td align="left">C<sub>20</sub>H<sub>24</sub>N<sub>2</sub>O<sub>7</sub></td> <td align="left">404.414</td> <td align="left">â€"1396.029</td> <td align="left">â€"1396.028</td> <td align="left">â€"1396.113</td> <td align="char" char=".">7.588</td> </tr> <tr> <td align="left"><b>5</b></td> <td align="left">C<sub>24</sub>H<sub>28</sub>N<sub>2</sub>O<sub>9</sub></td> <td align="left">488.487</td> <td align="left">â€"1697.825</td> <td align="left">â€"1697.824</td> <td align="left">â€"1697.924</td> <td align="char" char=".">3.865</td> </tr> <tr> <td align="left"><b>6</b></td> <td align="left">C<sub>22</sub>H<sub>28</sub>N<sub>2</sub>O<sub>11</sub>S<sub>2</sub></td> <td align="left">560.595</td> <td align="left">â€"2562.166</td> <td align="left">â€"2562.165</td> <td align="left">â€"2562.270</td> <td align="char" char=".">5.001</td> </tr> <tr> <td align="left"><b>7</b></td> <td align="left">C<sub>30</sub>H<sub>40</sub>N<sub>2</sub>O<sub>9</sub></td> <td align="left">572.647</td> <td align="left">â€"1930.556</td> <td align="left">â€"1930.555</td> <td align="left">â€"1930.676</td> <td align="char" char=".">4.123</td> </tr> <tr> <td align="left"><b>8</b></td> <td align="left">C<sub>32</sub>H<sub>44</sub>N<sub>2</sub>O<sub>9</sub></td> <td align="left">600.700</td> <td align="left">â€"2008.131</td> <td align="left">â€"2008.130</td> <td align="left">â€"2008.257</td> <td align="char" char=".">4.166</td> </tr> <tr> <td align="left"><b>9</b></td> <td align="left">C<sub>40</sub>H<sub>60</sub>N<sub>2</sub>O<sub>9</sub></td> <td align="left">712.912</td> <td align="left">â€"2318.429</td> <td align="left">â€"2318.428</td> <td align="left">â€"2318.583</td> <td align="char" char=".">4.230</td> </tr> <tr> <td align="left"><b>10</b></td> <td align="left">C<sub>44</sub>H<sub>68</sub>N<sub>2</sub>O<sub>9</sub></td> <td align="left">769.019</td> <td align="left">â€"2473.580</td> <td align="left">â€"2473.579</td> <td align="left">â€"2473.746</td> <td align="char" char=".">2.274</td> </tr> <tr> <td align="left"><b>11</b></td> <td align="left">C<sub>48</sub>H<sub>76</sub>N<sub>2</sub>O<sub>9</sub></td> <td align="left">825.125</td> <td align="left">â€"2628.727</td> <td align="left">â€"2628.726</td> <td align="left">â€"2628.909</td> <td align="char" char=".">4.249</td> </tr> <tr> <td align="left"><b>12</b></td> <td align="left">C<sub>52</sub>H<sub>84</sub>N<sub>2</sub>O<sub>9</sub></td> <td align="left">881.231</td> <td align="left">â€"2783.876</td> <td align="left">â€"2783.875</td> <td align="left">â€"2784.072</td> <td align="char" char=".">4.253</td> </tr> <tr> <td align="left"><b>13</b></td> <td align="left">C<sub>34</sub>H<sub>30</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>9</sub></td> <td align="left">681.516</td> <td align="left">â€"2990.069</td> <td align="left">â€"2990.068</td> <td align="left">â€"2990.189</td> <td align="char" char=".">6.206</td> </tr> <tr> <td align="left"><b>14</b></td> <td align="left">C<sub>34</sub>H<sub>30</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>9</sub></td> <td align="left">681.516</td> <td align="left">â€"2990.070</td> <td align="left">â€"2990.069</td> <td align="left">â€"2990.190</td> <td align="char" char=".">6.300</td> </tr> <tr> <td align="left"><b>15</b></td> <td align="left">C<sub>34</sub>H<sub>28</sub>Cl<sub>4</sub>N<sub>2</sub>O<sub>9</sub></td> <td align="left">750.406</td> <td align="left">â€"3903.457</td> <td align="left">â€"3903.456</td> <td align="left">â€"3903.584</td> <td align="char" char=".">7.619</td> </tr> </tbody> </table> </div> <div class="frontiermolecularorbitalanalysis" title="sec"><span class="label" tagx="label" title="label">3.3.1.</span><div class="title" tagx="title" title="title">
Frontier molecular orbital analysis</div> <p>The HOMO and LUMO energies, HOMO-LUMO gap (Î"ï¿½ï¿½ï¿½ï¿½), hardness (<i>Î·</i>), softness (<i>S</i>) and chemical potential (<i>Âµ</i>) index of all compounds are presented in <a href="#t0006">Table 7</a> (<a href="#F0006">Figure 6</a>). According to the frontier molecular orbital theory, energies of HOMO and LUMO play an important role in chemical reactivity. The HOMO-LUMO gap is also related to the chemical hardness, softness, chemical potential and electrophilic index of a molecule (Cohen &amp;amp; Benson, <a href="#CIT0006">1993</a>; Lien et al., <a href="#CIT0023">1982</a>). Large HOMO-LUMO gap is responsible for high kinetic stability and low chemical reactivity. On the other hand, small HOMO-LUMO gap is important for low chemical stability, because addition of electrons to a high-lying LUMO and/or removal of electrons from a low-lying HOMO is energetically favorable in any potential reaction. In these esters <b>4</b>â€"<b>15</b>, Î"ï¿½ï¿½ï¿½ï¿½ value was found lower than uridine (<b>1</b>), and thus, favorable for energetically favorable reaction. We noticed that, with the increase of the number of ester group(s) and chain length (<b>4</b>â€"<b>15</b>) hardness of these compounds gradually decreased while their softness gradually increased. All these properties may contribute to show higher chemical activity and polarizability in the drug related chemical and biochemical functionalities.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 6.</span></a></div>   <p>Frontier molecular orbital and related energy of uridine derivatives <b>5</b> and <b>15</b>.</p>   </div> <div class="table-wrap_UNKNOWN" id="t0007" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 7.</span> <p>Energy (eV) of HOMO, LUMO, Gap (Î"ï¿½ï¿½ï¿½ï¿½), hardness (<i>Î·</i>), softness (<i>S</i>) and chemical potential (<i>Î¼</i>) of uridine (<b>1</b>) and its esters <b>4</b>â€"<b>15</b>.</p>  <table frame="hsides" rules="groups"> <colgroup> <col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup>  <thead> <tr> <th align="left">Drug</th> <th align="center">â€ƒHOMO</th> <th align="center">â€ƒLUMO</th> <th align="center">Gap (Î"ï¿½ï¿½ï¿½ï¿½)</th> <th align="center"><i>Î·</i></th> <th align="center"><i>S</i></th> <th align="center"><i>Î¼</i></th> </tr> </thead> <tbody valign="top"> <tr> <td align="left"><b>1</b></td> <td align="left">â€"9.896</td> <td align="left">2.848</td> <td align="left">12.744</td> <td align="left">6.372</td> <td align="char" char=".">0.157</td> <td align="left">â€"3.524</td> </tr> <tr> <td align="left"><b>4</b></td> <td align="left">â€"9.157</td> <td align="left">2.812</td> <td align="left">11.969</td> <td align="left">5.985</td> <td align="char" char=".">0.167</td> <td align="left">â€"3.173</td> </tr> <tr> <td align="left"><b>5</b></td> <td align="left">â€"9.169</td> <td align="left">2.777</td> <td align="left">11.946</td> <td align="left">5.973</td> <td align="char" char=".">0.167</td> <td align="left">â€"3.196</td> </tr> <tr> <td align="left"><b>6</b></td> <td align="left">â€"9.262</td> <td align="left">2.638</td> <td align="left">11.900</td> <td align="left">5.950</td> <td align="char" char=".">0.168</td> <td align="left">â€"3.312</td> </tr> <tr> <td align="left"><b>7</b></td> <td align="left">â€"9.154</td> <td align="left">2.798</td> <td align="left">11.952</td> <td align="left">5.976</td> <td align="char" char=".">0.167</td> <td align="left">â€"3.178</td> </tr> <tr> <td align="left"><b>8</b></td> <td align="left">â€"9.152</td> <td align="left">2.801</td> <td align="left">11.953</td> <td align="left">5.977</td> <td align="char" char=".">0.167</td> <td align="left">â€"3.176</td> </tr> <tr> <td align="left"><b>9</b></td> <td align="left">â€"9.149</td> <td align="left">2.804</td> <td align="left">11.953</td> <td align="left">5.977</td> <td align="char" char=".">0.167</td> <td align="left">â€"3.173</td> </tr> <tr> <td align="left"><b>10</b></td> <td align="left">â€"9.144</td> <td align="left">2.811</td> <td align="left">11.955</td> <td align="left">5.978</td> <td align="char" char=".">0.167</td> <td align="left">â€"3.167</td> </tr> <tr> <td align="left"><b>11</b></td> <td align="left">â€"9.148</td> <td align="left">2.805</td> <td align="left">11.953</td> <td align="left">5.977</td> <td align="char" char=".">0.167</td> <td align="left">â€"3.172</td> </tr> <tr> <td align="left"><b>12</b></td> <td align="left">â€"9.148</td> <td align="left">2.805</td> <td align="left">11.953</td> <td align="left">5.977</td> <td align="char" char=".">0.167</td> <td align="left">â€"3.172</td> </tr> <tr> <td align="left"><b>13</b></td> <td align="left">â€"9.174</td> <td align="left">1.771</td> <td align="left">10.945</td> <td align="left">5.473</td> <td align="char" char=".">0.183</td> <td align="left">â€"3.702</td> </tr> <tr> <td align="left"><b>14</b></td> <td align="left">â€"9.239</td> <td align="left">1.781</td> <td align="left">11.020</td> <td align="left">5.510</td> <td align="char" char=".">0.181</td> <td align="left">â€"3.729</td> </tr> <tr> <td align="left"><b>15</b></td> <td align="left">â€"9.090</td> <td align="left">1.735</td> <td align="left">10.825</td> <td align="left">5.413</td> <td align="char" char=".">0.185</td> <td align="left">â€"3.677</td> </tr> </tbody> </table> </div> </div> </div> <div class="moleculardockingresults" title="sec"><span class="label" tagx="label" title="label">3.4.</span><div class="title" tagx="title" title="title">
Molecular docking results</div> <p>Estimation of the feasible binding geometries and interactions between drugs and active site of proteins (Matin, Bhattacharjee, et al., <a href="#CIT0028">2019</a>; Matin, Bhuiyan, et al., <a href="#CIT0032">2019</a>) is obtained from molecular docking (Ghosh et al., <a href="#CIT0011">2020</a>). Molecular docking score of esters <b>4</b>â€"<b>15</b> along with standard antibiotic ampicillin (AMP) and hydroxychloroquine (HCQ) are shown in <a href="#t0007">Table 8</a>. We calculated docking score (binding affinity) of <b>13</b>â€"<b>14</b>, as these chlorobenzoyl compounds showed promising antifungal activities, with lanosterol 14Î±-demethylase (CYP51A1) and <i>A. flavus</i> (1R51) while all the uridine esters were considered for COVID-19 main protease (7BQY). In addition, other uridine esters <b>4</b>â€"<b>12</b> expressed, in average, somewhat lower docking score than <b>13</b>â€"<b>14</b> against CYP51A1 and 1R51.</p> <div class="table-wrap_UNKNOWN" id="t0008" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 8.</span> <p>Molecular docking score of <b>4</b>â€"<b>15</b>.</p>  <table frame="hsides" rules="groups"> <colgroup> <col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup>  <thead> <tr> <th align="left">Drugs</th> <th align="center">CYP51A1 (kcal/mol)</th> <th align="center">1R51 (kcal/mol)</th> <th align="center">7BQY (kcal/mol)</th> </tr> </thead> <tbody valign="top"> <tr> <td align="left"><b>4</b></td> <td align="center">â€"8.8</td> <td align="center">â€"8.1</td> <td align="center">â€"7.7</td> </tr> <tr> <td align="left"><b>5</b></td> <td align="center">â€"9.0</td> <td align="center">â€"7.3</td> <td align="center">â€"7.9</td> </tr> <tr> <td align="left"><b>6</b></td> <td align="center">â€"8.5</td> <td align="center">â€"7.2</td> <td align="center">â€"6.6</td> </tr> <tr> <td align="left"><b>7</b></td> <td align="center">â€"7.5</td> <td align="center">â€"7.5</td> <td align="center">â€"8.0</td> </tr> <tr> <td align="left"><b>8</b></td> <td align="center">â€"9.2</td> <td align="center">â€"6.4</td> <td align="center">â€"8.0</td> </tr> <tr> <td align="left"><b>9</b></td> <td align="center">â€"9.0</td> <td align="center">â€"6.0</td> <td align="center">â€"6.4</td> </tr> <tr> <td align="left"><b>10</b></td> <td align="center">â€"5.4</td> <td align="center">â€"5.8</td> <td align="center">â€"5.5</td> </tr> <tr> <td align="left"><b>11</b></td> <td align="center">â€"6.6</td> <td align="center">â€"6.3</td> <td align="center">â€"4.9</td> </tr> <tr> <td align="left"><b>12</b></td> <td align="center">â€"4.5</td> <td align="center">â€"5.8</td> <td align="center">â€"5.2</td> </tr> <tr> <td align="left"><b>13</b></td> <td align="center">â€"12.0</td> <td align="center">â€"9.3</td> <td align="center">â€"7.7</td> </tr> <tr> <td align="left"><b>14</b></td> <td align="center">â€"11.1</td> <td align="center">â€"7.7</td> <td align="center">â€"7.6</td> </tr> <tr> <td align="left"><b>15</b></td> <td align="center">â€"8.3</td> <td align="center">â€"8.0</td> <td align="center">â€"7.8</td> </tr> <tr> <td align="left"><b>AMP</b></td> <td align="center">â€"7.9</td> <td align="center">â€"7.5</td> <td align="center">â€"</td> </tr> <tr> <td align="left"><b>HCQ</b></td> <td align="center">â€"</td> <td align="center">â€"</td> <td align="center">â€"6.1</td> </tr> </tbody> </table> </div> <p>Ampicillin (AMP) and HCQ were used as standard drugs; Discovery Studio (version 4.1) was performed for analysis and view of docking results.</p> <p>Docking score clearly indicated that chlorobenzoyl esters <b>13</b>â€"<b>15</b> had binding energy with both the CYP51A1 (â€"7.9 to â€"12.0â€‰kcal/mol; <a href="#F0007">Figure 7(a,b)</a>) and 1R51 (â€"7.5 to â€"9.3â€‰kcal/mol; <a href="#F0007">Figure 7(c,d)</a>) proteins which were higher than the standard antibiotic ampicillin (â€"7.9 and â€"7.5â€‰kcal/mol). The results are in complete accord with the <i>in vitro</i> results (<a href="#t0004">Table 5</a>) that these uridine esters had better antifungal activities.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 7.</span></a></div>   <p>(a) Docking pose (represented in space-filling model) of <b>13</b>, <b>14</b> and ampicillin with CYP51A1; (b) 2D interaction map of <b>13</b>, <b>14</b> and ampicillin with CYP51A1; (c) Docking pose of <b>14</b>, <b>15</b> and ampicillin with 1R51; (d) 2D interaction map of <b>14</b>, <b>15</b> and ampicillin with 1R51.</p>   </div> <p>Considering the current COVID-19 pandemic caused by the SARS-CoV-2 betacoronavirus (Ghosh et al., <a href="#CIT0011">2020</a>; Lakshmi et al., <a href="#CIT0021">2020</a>) we have extended our studies by docking with COVID-19 main protease (7BQY). As shown in <a href="#t0007">Table 8</a>, most of the uridine esters showed higher binding affinity with 7BQY than HCQ (â€"6.1â€‰Kcal/mol). It is worth to mention that saturated fatty acyl esters with <b>5</b>, <b>7</b>â€"<b>8</b> smaller chain length exhibited better binding affinity than the higher chain length <b>9</b>â€"<b>12</b>, sulphonyl ester <b>6</b> and chlorobenzoyl esters <b>13</b>â€"<b>15</b> (<a href="#F0008">Figure 8</a>). The docking score of <b>5</b>, <b>7</b> and <b>8</b> (â€"7.9 to â€"8.0â€‰kcal/mol) were found to better than the previously published other compounds (Ghosh et al., <a href="#CIT0011">2020</a>). Thus, uridine aliphatic esters could be better choice than HCQ in treating COVID-19 infection.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 8.</span></a></div>   <p>(a) Docked pose (represented in space-filling model) and (b) 2D interaction map of <b>13</b>, <b>14, 15</b> and HCQ with 7BQY.</p>   </div> </div> <div class="cytotoxicactivityoftheuridineesters4â€" title="sec"><span class="label" tagx="label" title="label">3.5.</span><div class="title" tagx="title" title="title">
Cytotoxic activity of the uridine esters 4â€"15</div> <p>The toxicity activity of the acylated uridine derivatives <b>4</b>â€"<b>15</b> in the brine shrimp lethality bioassay method (McLaughlin, <a href="#CIT0038">1991</a>) is presented in <a href="#F0009">Figure 9</a>, which showed the percentage of mortality of shrimps at 24â€‰h and 48â€‰h. From the data, it was evident that the test chemicals 5â€²Ë—<i>O</i>Ë—(4Ë—<i>tË—</i>butylbenzoyl)Ë—2â€²,3â€²Ë—diË—<i>O</i>Ë—pentanoyl-uridine (<b>7</b>) and 5â€²-<i>O</i>-(4-<i>t</i>-butylbenzoyl)-2â€²,3â€²-di-<i>O</i>-lauroyluridine (<b>10</b>) showed highest levels of toxicity (i.e. âˆ¼57% death) indicating its higher mortality. The rest of the compounds were found less toxic for brine shrimp (<a href="#F0009">Figure 9</a>).</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 9.</span></a></div>   <p>Cytotoxic activity of the uridine esters <b>4</b>â€"<b>15</b>.</p>   </div> </div> <div class="adme/tproperties" title="sec"><span class="label" tagx="label" title="label">3.6.</span><div class="title" tagx="title" title="title">
ADME/T properties</div> <p>Absorption, distribution, metabolism, excretion and toxicity (ADMET) related pharmacokinetic profile is mentioned in <a href="#t0008">Table 9</a>. It is evident that these compounds possess better absorption value than standard antibiotics (ampicillin and nystatin) although they are P-glycoprotein inhibitor (except <b>15</b>). Distribution like BBB (&amp;gt;â€"1) and CNS (&amp;gt;â€"2) permeability values are comparable to standard drugs. Compounds <b>4</b>â€"<b>14</b> are CYP3A4 enzyme substrate while <b>15</b> is non-substrate for this enzyme. Their excretion, presented as total clearance, is comparable to ampicillin.</p> <div class="table-wrap_UNKNOWN" id="t0009" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 9.</span> <p>ADMET calculation of uridine derived esters <b>4</b>â€"<b>15</b>.</p>  <table frame="hsides" rules="groups"> <colgroup> <col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup>  <thead> <tr> <th rowspan="3" align="left">Drug</th> <th colspan="3" align="center">Absorption <hr /> </th> <th colspan="2" align="center">Distribution <hr /> </th> <th align="center">Metabolism</th> <th align="center">Excretion</th> <th colspan="2" align="center">Toxicity <hr /> </th> </tr> <tr> <th rowspan="2" align="center">C2P</th> <th rowspan="2" align="center">HIA<br /><br />(%)</th> <th rowspan="2" align="center">P-gpI</th> <th align="center">BBB</th> <th align="center">CNS</th> <th rowspan="2" align="center">CYP3A4 substrate</th> <th rowspan="2" align="center">Total clearance</th> <th rowspan="2" align="center">hERG<br /><br />inhibitor</th> <th rowspan="2" align="center">Acute<br /><br />LD50</th> </tr> <tr> <th colspan="2" align="center">(permeability)</th> </tr> </thead> <tbody valign="top"> <tr> <td align="left"><b>1</b></td> <td align="center">â€"0.149</td> <td align="center">50.745</td> <td align="center">No</td> <td align="center">â€"1.401</td> <td align="center">â€"4.44</td> <td align="center">No</td> <td align="center">0.662</td> <td align="center">No</td> <td align="center">2.032</td> </tr> <tr> <td align="left"><b>4</b></td> <td align="center">0.849</td> <td align="center">64.746</td> <td align="center">Yes</td> <td align="center">â€"1.269</td> <td align="center">â€"3.577</td> <td align="center">Yes</td> <td align="center">1.05</td> <td align="center">No</td> <td align="center">2.156</td> </tr> <tr> <td align="left"><b>5</b></td> <td align="center">â€"0.307</td> <td align="center">73.091</td> <td align="center">Yes</td> <td align="center">â€"1.516</td> <td align="center">â€"3.533</td> <td align="center">Yes</td> <td align="center">0.675</td> <td align="center">No</td> <td align="center">1.94</td> </tr> <tr> <td align="left"><b>6</b></td> <td align="center">â€"0.356</td> <td align="center">64.449</td> <td align="center">Yes</td> <td align="center">â€"2.322</td> <td align="center">â€"4.004</td> <td align="center">Yes</td> <td align="center">0.519</td> <td align="center">No</td> <td align="center">2.068</td> </tr> <tr> <td align="left"><b>7</b></td> <td align="center">â€"0.386</td> <td align="center">80.936</td> <td align="center">Yes</td> <td align="center">â€"1.038</td> <td align="center">â€"3.206</td> <td align="center">Yes</td> <td align="center">0.79</td> <td align="center">No</td> <td align="center">2.379</td> </tr> <tr> <td align="left"><b>8</b></td> <td align="center">â€"0.431</td> <td align="center">76.614</td> <td align="center">Yes</td> <td align="center">â€"1.042</td> <td align="center">â€"3.11</td> <td align="center">Yes</td> <td align="center">0.822</td> <td align="center">No</td> <td align="center">2.588</td> </tr> <tr> <td align="left"><b>9</b></td> <td align="center">â€"0.654</td> <td align="center">82.458</td> <td align="center">Yes</td> <td align="center">â€"1.081</td> <td align="center">â€"2.883</td> <td align="center">Yes</td> <td align="center">0.943</td> <td align="center">No</td> <td align="center">2.866</td> </tr> <tr> <td align="left"><b>10</b></td> <td align="center">â€"0.764</td> <td align="center">85.355</td> <td align="center">Yes</td> <td align="center">â€"1.099</td> <td align="center">â€"2.836</td> <td align="center">Yes</td> <td align="center">0.855</td> <td align="center">No</td> <td align="center">2.769</td> </tr> <tr> <td align="left"><b>11</b></td> <td align="center">â€"0.874</td> <td align="center">88.256</td> <td align="center">Yes</td> <td align="center">â€"1.117</td> <td align="center">â€"2.79</td> <td align="center">Yes</td> <td align="center">0.913</td> <td align="center">No</td> <td align="center">2.645</td> </tr> <tr> <td align="left"><b>12</b></td> <td align="center">â€"0.984</td> <td align="center">91.157</td> <td align="center">Yes</td> <td align="center">â€"1.136</td> <td align="center">â€"2.743</td> <td align="center">Yes</td> <td align="center">0.972</td> <td align="center">No</td> <td align="center">2.543</td> </tr> <tr> <td align="left"><b>13</b></td> <td align="center">â€"0.311</td> <td align="center">97.276</td> <td align="center">Yes</td> <td align="center">â€"1.155</td> <td align="center">â€"2.956</td> <td align="center">Yes</td> <td align="center">0.377</td> <td align="center">No</td> <td align="center">2.317</td> </tr> <tr> <td align="left"><b>14</b></td> <td align="center">â€"0.213</td> <td align="center">97.221</td> <td align="center">Yes</td> <td align="center">â€"1.188</td> <td align="center">â€"2.936</td> <td align="center">Yes</td> <td align="center">0.503</td> <td align="center">No</td> <td align="center">2.315</td> </tr> <tr> <td align="left"><b>15</b></td> <td align="center">â€"0.276</td> <td align="center">100</td> <td align="center">No</td> <td align="center">â€"1.554</td> <td align="center">â€"2.846</td> <td align="center">No</td> <td align="center">0.026</td> <td align="center">No</td> <td align="center">2.284</td> </tr> <tr> <td align="left"><b>AMP</b></td> <td align="center">0.395</td> <td align="center">43.034</td> <td align="center">No</td> <td align="center">â€"0.767</td> <td align="center">â€"3.166</td> <td align="center">No</td> <td align="center">0.337</td> <td align="center">No</td> <td align="center">1.637</td> </tr> <tr> <td align="left"><b>NYS</b></td> <td align="center">â€"0.609</td> <td align="center">0.00</td> <td align="center">No</td> <td align="center">â€"2.09</td> <td align="center">â€"3.702</td> <td align="center">No</td> <td align="center">â€"1.357</td> <td align="center">No</td> <td align="center">2.518</td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p>C2P: Caco-2 permeability (log Papp in 10<sup>-6â€‰</sup>cm/s, &amp;gt;0.90 indicates high permeability); HIA: Human intestinal absorption (% absorbed, &amp;gt;30% is better absorbed); P-gpI: P-glycoprotein inhibitor; BBB (blood brain barrier) is expressed in logBB (logBB &amp;gt;-1.0 is moderately cross blood brain barrier); CNS (central nervous system) is expressed as logPS (logPS &amp;gt; â€"2.0 can easily penetrate the CNS); Total clearance is expressed in log mL/min/kg; hERG: human ether-Ã -go-go-related gene I; Toxicity is calculated in oral rat acute toxicity (mol/kg); AMP: ampicillin; NYS: nystatin.</p> </div> </div> </div> <p>We have also calculated their toxicity values along with standard antibiotics. hERG (human etherâ€�Ã â€�goâ€�goâ€�related gene I) showed negative values for these compounds like nystatin. Hence, these compounds could be safe and will not generate QT syndrome like fatal ventricular arrhythmia (Matin, Bhattacharjee, et al., <a href="#CIT0028">2019</a>; Matin, Bhuiyan, et al., <a href="#CIT0032">2019</a>; Matin, Chakraborty, et al., <a href="#CIT0034">2020</a>). In addition, it is important to consider the lethal dosage (LD<sub>50</sub>) values and is used to assess the relative toxicity of different molecules. Here, most of the ester's LD<sub>50</sub> values (&amp;lt;3â€‰mol/kg) are in good consistent with the value of nystatin (2.52â€‰mol/kg).</p> <p>Drug likeness calculations were calculated from SwissADME tool and are summarized in <a href="#t0009">Table 10</a>. For comparison both the uridine esters and standard antibiotics' drug likeness values were calculated. It was found that all the esters (except mesylate <b>6</b>) have good hydrogen bonds donor and acceptor which is in consistent with the Lipnski's rule of five. The more the value topological polar surface area (TPSA) more the polarity of the compounds and should be less than 140 Ã…<sup>2</sup>. The TPSA in these molecules was in excellent agreement (âˆ¼143 Ã…<sup>2</sup>) with the most important rules of drug likeness (Lipinski et al., <a href="#CIT0024">1997</a>).</p> <div class="table-wrap_UNKNOWN" id="t0010" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 10.</span> <p>Calculation drug likeness using SwissADME.</p>  <table frame="hsides" rules="groups"> <colgroup> <col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup> <colgroup><col width="80pt" /></colgroup>  <thead> <tr> <th align="left">Drug</th> <th align="center">HB acceptors</th> <th align="center">HB donors</th> <th align="center">TPSA<br /><br />Ã…Â²</th> <th align="center">CYP1A2 inhibitor</th> <th align="center">CYP2C19 inhibitor</th> <th align="center">CYP2C9 inhibitor</th> <th align="center">CYP2D6 inhibitor</th> <th align="center">CYP3A4 inhibitor</th> <th align="center">PAINS alerts</th> </tr> </thead> <tbody valign="top"> <tr> <td align="left"><b>1</b></td> <td align="center">6</td> <td align="center">4</td> <td align="center">124.78</td> <td align="center">No</td> <td align="center">No</td> <td align="center">No</td> <td align="center">No</td> <td align="center">No</td> <td align="center">0</td> </tr> <tr> <td align="left"><b>4</b></td> <td align="center">7</td> <td align="center">3</td> <td align="center">130.85</td> <td align="center">No</td> <td align="center">No</td> <td align="center">No</td> <td align="center">No</td> <td align="center">No</td> <td align="center">0</td> </tr> <tr> <td align="left"><b>5</b></td> <td align="center">9</td> <td align="center">1</td> <td align="center">142.99</td> <td align="center">No</td> <td align="center">No</td> <td align="center">No</td> <td align="center">No</td> <td align="center">Yes</td> <td align="center">0</td> </tr> <tr> <td align="left"><b>6</b></td> <td align="center">11</td> <td align="center">1</td> <td align="center">193.89</td> <td align="center">No</td> <td align="center">No</td> <td align="center">No</td> <td align="center">No</td> <td align="center">Yes</td> <td align="center">0</td> </tr> <tr> <td align="left"><b>7</b></td> <td align="center">9</td> <td align="center">1</td> <td align="center">142.99</td> <td align="center">No</td> <td align="center">No</td> <td align="center">Yes</td> <td align="center">Yes</td> <td align="center">Yes</td> <td align="center">0</td> </tr> <tr> <td align="left"><b>8</b></td> <td align="center">9</td> <td align="center">1</td> <td align="center">142.99</td> <td align="center">No</td> <td align="center">No</td> <td align="center">Yes</td> <td align="center">Yes</td> <td align="center">Yes</td> <td align="center">0</td> </tr> <tr> <td align="left"><b>9</b></td> <td align="center">9</td> <td align="center">1</td> <td align="center">142.99</td> <td align="center">No</td> <td align="center">No</td> <td align="center">No</td> <td align="center">No</td> <td align="center">No</td> <td align="center">0</td> </tr> <tr> <td align="left"><b>10</b></td> <td align="center">9</td> <td align="center">1</td> <td align="center">142.99</td> <td align="center">No</td> <td align="center">No</td> <td align="center">No</td> <td align="center">No</td> <td align="center">No</td> <td align="center">0</td> </tr> <tr> <td align="left"><b>11</b></td> <td align="center">9</td> <td align="center">1</td> <td align="center">142.99</td> <td align="center">No</td> <td align="center">No</td> <td align="center">No</td> <td align="center">No</td> <td align="center">No</td> <td align="center">0</td> </tr> <tr> <td align="left"><b>12</b></td> <td align="center">9</td> <td align="center">1</td> <td align="center">142.99</td> <td align="center">No</td> <td align="center">No</td> <td align="center">No</td> <td align="center">No</td> <td align="center">No</td> <td align="center">0</td> </tr> <tr> <td align="left"><b>13</b></td> <td align="center">9</td> <td align="center">1</td> <td align="center">142.99</td> <td align="center">No</td> <td align="center">No</td> <td align="center">Yes</td> <td align="center">No</td> <td align="center">No</td> <td align="center">0</td> </tr> <tr> <td align="left"><b>14</b></td> <td align="center">9</td> <td align="center">1</td> <td align="center">142.99</td> <td align="center">No</td> <td align="center">No</td> <td align="center">Yes</td> <td align="center">No</td> <td align="center">No</td> <td align="center">0</td> </tr> <tr> <td align="left"><b>15</b></td> <td align="center">9</td> <td align="center">1</td> <td align="center">142.99</td> <td align="center">No</td> <td align="center">No</td> <td align="center">No</td> <td align="center">No</td> <td align="center">No</td> <td align="center">0</td> </tr> <tr> <td align="left"><b>AMP</b></td> <td align="center">5</td> <td align="center">3</td> <td align="center">138.03</td> <td align="center">No</td> <td align="center">No</td> <td align="center">No</td> <td align="center">No</td> <td align="center">No</td> <td align="center">0</td> </tr> <tr> <td align="left"><b>NYS</b></td> <td align="center">18</td> <td align="center">12</td> <td align="center">319.61</td> <td align="center">No</td> <td align="center">No</td> <td align="center">No</td> <td align="center">No</td> <td align="center">No</td> <td align="center">0</td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p>*HB: hydrogen bond; TPSA: topological polar surface area, PAINS: Pan-assay interference compounds, AMP: ampicillin, NYS: nystatin.</p> </div> </div> </div> <p>In the present study, we have checked the CYP enzymes, particularly isoforms 1A2, 2C9, 2C19, 2D6 and 3A4, inhibitory activities which are responsible for about 90% oxidative metabolic reactions. Inhibition of CYP enzymes will lead to inductive or inhibitory failure of drug metabolism. These inhibitions of compound <b>4</b>, <b>9</b>â€"<b>12</b> and <b>15</b> were found similar to that of the standard drugs (<a href="#t0009">Table 10</a>). In addition, Pan-assay interference compounds (PAINS) revealed no violation with these uridine esters. PAINS are chemical compounds that often give false positive results in high-throughput screens. PAINS tend to react nonspecifically with numerous biological targets rather than specifically affecting one desired target. Many studies indicated the acute toxic effects of medicines on non-targeted organisms, and hence, the MTT, MTS and Resazurin assay methods are used to check the cytotoxic concentration of any new molecule (synthetic or natural) which gives an idea about the maximum nontoxic dose of the drug molecule. We hope to conduct such studies for the more drug related validation of these promising uridine compounds.</p> </div> <div class="structureâ€" title="sec"><span class="label" tagx="label" title="label">3.7.</span><div class="title" tagx="title" title="title">
Structureâ€"activity relationship</div> <p>It was observed that the most of the potential antifungal drugs (fluconazole; itraconazole; voriconazole; terbinafine) are designed to deter the activity of CYP51A1 enzyme to synthesize essential ergosterol (Matin, Chakraborty, et al., <a href="#CIT0033">2020</a>; Matin, Hasan, et al., <a href="#CIT0034">2020</a>; Matin, Roshid, et al., <a href="#CIT0037">2020</a>). On the basis of our study, it could be thought that the effective uridine esters <b>13</b>â€"<b>15</b> restricted CYP51 enzyme activity by binding with it, and hence, fungal ergosterol could not form. The unavailability of ergosterol ultimately causes disruption of the fungal cell wall causing organisms death.</p> <p>On the other hand, saturated fatty acyl esters with <b>5</b>, <b>7</b>â€"<b>8</b> smaller chain length (C2â€"C6) showed slightly better binding score (â€"7.9 to â€"8.0â€‰kcal/mol) than chlorobenzoyl esters <b>13</b>â€"<b>15</b> (â€"7.6 to â€"7.8â€‰kcal/mol) with 7BQY (COVID-19 main protease). Methanesuphonyl ester <b>6</b> (â€"6.6â€‰kcal/mol) and HQC (â€"6.1â€‰kcal/mol) had lower binding energy. The present results, thus, might have pave the way for discovery of novel drugs related to COVID-19 treatment although related further study is needed.</p> </div> </div> <div class="conclusion" title="sec"><span class="label" tagx="label" title="label">4.</span><div class="title" tagx="title" title="title">
Conclusion</div> <p>Covid-19, toxicity and evolution of MDR organisms in the microbial world caused a huge threat, and hence, novel antiviral and antimicrobial drugs preferably with newer mode of action, and reduced side-effects are essential. In this context several uridine esters were analyzed <i>in vitro</i> and <i>in silico</i> for their antimicrobial, thermodynamic, molecular docking and drug likeness properties. The study revealed that chloro-substituted benzoyl esters <b>13</b>â€"<b>15</b> of uridine were more potential against fungal organisms with better pharmacokinetic and drug likeness spectra. In addition, some aliphatic acyl esters especially with lower carbon chains (C2-C6) showed promising binding score with COVID-19 main protease (7BQY). In this promising context, more drug likeness <i>in vitro</i> and <i>in vivo</i> study such as nontoxic concentration towards healthy cells may be conducted in the near future.</p> </div> </div> <div class="back" title="back"> <div class="ack" title="ack"> <div class="title" tagx="title" title="title">
Acknowledgements</div> <p>S. A. Chowdhury would like to thank Ministry of Science and Technology, Bangladesh for PhD fellowship. The authors are grateful to the Institute of Marine Science, University of Chittagong, Bangladesh and the Department of Physiology, Biochemistry &amp;amp; Pharmacology, University of Chittagong Veterinary and Animal Science, Bangladesh for providing facilities during cytotoxic and antimicrobial evaluation.</p> </div> <div class="COI-statement" title="COI-statement"> <div class="title" tagx="title" title="title">
Disclosure statement</div> <p>No potential conflict of interest was reported by the authors.</p> </div> <div class="references">
References</div> <div tag="ref-list"> <ul> <div class="title" tagx="title" title="title">
References</div> <li tag="ref"><a name="CIT0001" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Awual</span><span class="given-names" tagx="given-names" title="given-names">M. R.</span></span></span> (<span class="year" tagx="year" title="year">2017</span>). <span class="mixed-article-title" title="mixed-article-title">New type mesoporous conjugate material for selective optical copper(II) ions monitoring &amp;amp; removal from polluted waters</span>. <span class="source" tagx="source" title="source"><i>Chemical Engineering Journal</i></span>, , <span class="fpage" tagx="fpage" title="fpage">85</span>â€"<span class="lpage" tagx="lpage" title="lpage">94</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1016/j.cej.2016.07.110">10.1016/j.cej.2016.07.110</a></span></span></li> <li tag="ref"><a name="CIT0002" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Banasch</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Goetze</span><span class="given-names" tagx="given-names" title="given-names">O.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Knyhala</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Potthoff</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Schlottmann</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kwiatek</span><span class="given-names" tagx="given-names" title="given-names">M. A.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bulut</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Schmitz</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Schmidt</span><span class="given-names" tagx="given-names" title="given-names">W. E.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Brockmeyer</span><span class="given-names" tagx="given-names" title="given-names">N. H.</span></span></span> (<span class="year" tagx="year" title="year">2006</span>). <span class="mixed-article-title" title="mixed-article-title">Uridine supplementation enhances hepatic mitochondrial function in thymidine-analogue treated HIV-infected patients</span>. <span class="source" tagx="source" title="source"><i>AIDS (London, England)</i></span>, (<span class="issue" tagx="issue" title="issue">11</span>), <span class="fpage" tagx="fpage" title="fpage">1554</span>â€"<span class="lpage" tagx="lpage" title="lpage">1556</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1097/01.aids.0000237373.38939.14">10.1097/01.aids.0000237373.38939.14</a></span></span></li> <li tag="ref"><a name="CIT0003" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Carlezon</span><span class="given-names" tagx="given-names" title="given-names">W. A.</span><span class="suffix" tagx="suffix" title="suffix">Jr.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mague</span><span class="given-names" tagx="given-names" title="given-names">S. D.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Parow</span><span class="given-names" tagx="given-names" title="given-names">A. M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Stoll</span><span class="given-names" tagx="given-names" title="given-names">A. L.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cohen</span><span class="given-names" tagx="given-names" title="given-names">B. M.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Renshaw</span><span class="given-names" tagx="given-names" title="given-names">P. F.</span></span></span> (<span class="year" tagx="year" title="year">2005</span>). <span class="mixed-article-title" title="mixed-article-title">Antidepressant-like effects of uridine and omega-3 fatty acids are potentiated by combined treatment in rats</span>. <span class="source" tagx="source" title="source"><i>Biological Psychiatry</i></span>, (<span class="issue" tagx="issue" title="issue">4</span>), <span class="fpage" tagx="fpage" title="fpage">343</span>â€"<span class="lpage" tagx="lpage" title="lpage">350</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1016/j.biopsych.2004.11.038">10.1016/j.biopsych.2004.11.038</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15705349">15705349</a></span></span></li> <li tag="ref"><a name="CIT0004" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chowdhury</span><span class="given-names" tagx="given-names" title="given-names">S. A.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bhuiyan</span><span class="given-names" tagx="given-names" title="given-names">M. M. R.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ozeki</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kawsar</span><span class="given-names" tagx="given-names" title="given-names">S. M. A.</span></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Simple and rapid synthesis of some nucleoside derivatives: Structural and spectral characterization</span>. <span class="source" tagx="source" title="source"><i>Current Chemistry Letters</i></span>, (<span class="issue" tagx="issue" title="issue">2</span>), <span class="fpage" tagx="fpage" title="fpage">83</span>â€"<span class="lpage" tagx="lpage" title="lpage">92</span>. <span class="pub-id"><a href="https://dx.doi.org/10.5267/j.ccl.2015.12.001">10.5267/j.ccl.2015.12.001</a></span></span></li> <li tag="ref"><a name="CIT0005" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Clayden</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Greeves</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Warren</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wothers</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span></span> (<span class="year" tagx="year" title="year">2012</span>). <span class="source" tagx="source" title="source"><i>Organic chemistry</i></span> (<span class="edition" tagx="edition" title="edition">2nd ed.,</span> p. <span class="fpage" tagx="fpage" title="fpage">1234</span>). <span class="publisher-name" tagx="publisher-name" title="publisher-name">Oxford University Press</span>.</span></li> <li tag="ref"><a name="CIT0006" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cohen</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Benson</span><span class="given-names" tagx="given-names" title="given-names">S. W.</span></span></span> (<span class="year" tagx="year" title="year">1993</span>). <span class="mixed-article-title" title="mixed-article-title">Estimation of heats of formation of organic compounds by additivity methods</span>. <span class="source" tagx="source" title="source"><i>Chemical Reviews</i></span>, (<span class="issue" tagx="issue" title="issue">7</span>), <span class="fpage" tagx="fpage" title="fpage">2419</span>â€"<span class="lpage" tagx="lpage" title="lpage">2438</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1021/cr00023a005">10.1021/cr00023a005</a></span></span></li> <li tag="ref"><a name="CIT0007" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">De Clercq</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span></span> (<span class="year" tagx="year" title="year">2011</span>). <span class="mixed-article-title" title="mixed-article-title">A 40-year journey in search of selective antiviral chemotherapy</span>. <span class="source" tagx="source" title="source"><i>Annual Review of Pharmacology and Toxicology</i></span>, , <span class="fpage" tagx="fpage" title="fpage">1</span>â€"<span class="lpage" tagx="lpage" title="lpage">24</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1146/annurev-pharmtox-010510-100228">10.1146/annurev-pharmtox-010510-100228</a></span></span></li> <li tag="ref"><a name="CIT0008" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dobolyi</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">JuhÃ¡sz</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">KovÃ¡cs</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kardos</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span></span> (<span class="year" tagx="year" title="year">2011</span>). <span class="mixed-article-title" title="mixed-article-title">Uridine function in the central nervous system</span>. <span class="source" tagx="source" title="source"><i>Current Topics in Medicinal Chemistry</i></span>, (<span class="issue" tagx="issue" title="issue">8</span>), <span class="fpage" tagx="fpage" title="fpage">1058</span>â€"<span class="lpage" tagx="lpage" title="lpage">1067</span>. <span class="pub-id"><a href="https://dx.doi.org/10.2174/156802611795347618">10.2174/156802611795347618</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21401495">21401495</a></span></span></li> <li tag="ref"><a name="CIT0009" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Du</span><span class="given-names" tagx="given-names" title="given-names">L.-H.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shen</span><span class="given-names" tagx="given-names" title="given-names">J.-H.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dong</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">N.-N.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cheng</span><span class="given-names" tagx="given-names" title="given-names">B.-Z.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ou</span><span class="given-names" tagx="given-names" title="given-names">Z.-M.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Luo</span><span class="given-names" tagx="given-names" title="given-names">X.-P.</span></span></span> (<span class="year" tagx="year" title="year">2018</span>). <span class="mixed-article-title" title="mixed-article-title">Enzymatic synthesis of nucleoside analogues from uridines and vinyl esters in a continuous-flow microreactor</span>. <span class="source" tagx="source" title="source"><i>RSC Advances</i></span>, (<span class="issue" tagx="issue" title="issue">23</span>), <span class="fpage" tagx="fpage" title="fpage">12614</span>â€"<span class="lpage" tagx="lpage" title="lpage">12618</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1039/c8ra01030g">10.1039/c8ra01030g</a></span></span></li> <li tag="ref"><a name="CIT0010" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Escober</span><span class="given-names" tagx="given-names" title="given-names">J. F. B.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Carmona</span><span class="given-names" tagx="given-names" title="given-names">V. H. A.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jaramillo</span><span class="given-names" tagx="given-names" title="given-names">E. G.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Margarita</span><span class="given-names" tagx="given-names" title="given-names">D. M. M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">FernÃ¡ndez</span><span class="given-names" tagx="given-names" title="given-names">M. E. M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Guerrero</span><span class="given-names" tagx="given-names" title="given-names">M. C.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">MartÃ­nez</span><span class="given-names" tagx="given-names" title="given-names">A. M.</span></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Synthesis and cytotoxic activity of tri-acyl ester derivatives of uridine in breast cancer cells</span>. <span class="source" tagx="source" title="source"><i>Ars Pharmaceutica</i></span>, (<span class="issue" tagx="issue" title="issue">4</span>), <span class="fpage" tagx="fpage" title="fpage">183</span>â€"<span class="lpage" tagx="lpage" title="lpage">191</span>. <span class="pub-id"><a href="https://dx.doi.org/10.4321/S2340-98942016000400005">10.4321/S2340-98942016000400005</a></span></span></li> <li tag="ref"><a name="CIT0011" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ghosh</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chakraborty</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Biswas</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chowdhuri</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span> (<span class="year" tagx="year" title="year">2020</span>). <span class="mixed-article-title" title="mixed-article-title">Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors â€" an <i>in silico</i> docking and molecular dynamics simulation study</span>. <span class="source" tagx="source" title="source"><i>Journal of Biomolecular Structure and Dynamics</i></span>. <span class="pub-id"><a href="https://dx.doi.org/10.1080/07391102.2020.1779818">10.1080/07391102.2020.1779818</a></span></span></li> <li tag="ref"><a name="CIT0012" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kabir</span><span class="given-names" tagx="given-names" title="given-names">A. K. M. S.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Matin</span><span class="given-names" tagx="given-names" title="given-names">M. M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ali</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Anwar</span><span class="given-names" tagx="given-names" title="given-names">M. N.</span></span></span> (<span class="year" tagx="year" title="year">2003</span>). <span class="mixed-article-title" title="mixed-article-title">Comparative studies on selective acylation and antimicrobial activities of some D-glucofuranose derivatives</span>. <span class="source" tagx="source" title="source"><i>Journal of Bangladesh Academy of Sciences</i></span>, (<span class="issue" tagx="issue" title="issue">1</span>), <span class="fpage" tagx="fpage" title="fpage">43</span>â€"<span class="lpage" tagx="lpage" title="lpage">50</span>.</span></li> <li tag="ref"><a name="CIT0013" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kabir</span><span class="given-names" tagx="given-names" title="given-names">A. K. M. S.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Matin</span><span class="given-names" tagx="given-names" title="given-names">M. M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Islam</span><span class="given-names" tagx="given-names" title="given-names">K. R.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Anwar</span><span class="given-names" tagx="given-names" title="given-names">M. N.</span></span></span> (<span class="year" tagx="year" title="year">2002</span>). <span class="mixed-article-title" title="mixed-article-title">Synthesis and antimicrobial activities of some acylated uridine derivatives</span>. <span class="source" tagx="source" title="source"><i>Journal of the Bangladesh Chemical Society</i></span>, (<span class="issue" tagx="issue" title="issue">1</span>), <span class="fpage" tagx="fpage" title="fpage">13</span>â€"<span class="lpage" tagx="lpage" title="lpage">22</span>.</span></li> <li tag="ref"><a name="CIT0014" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kabir</span><span class="given-names" tagx="given-names" title="given-names">A. K. M. S.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Matin</span><span class="given-names" tagx="given-names" title="given-names">M. M.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kawsar</span><span class="given-names" tagx="given-names" title="given-names">S. M. A.</span></span></span> (<span class="year" tagx="year" title="year">1997</span>). <span class="mixed-article-title" title="mixed-article-title">Selective acylation of uridine using the dibutyltin oxide and direct methods</span>. <span class="source" tagx="source" title="source"><i>Chittagong University Studies, Part II: Science</i></span>, (<span class="issue" tagx="issue" title="issue">2</span>), <span class="fpage" tagx="fpage" title="fpage">39</span>â€"<span class="lpage" tagx="lpage" title="lpage">45</span>.</span></li> <li tag="ref"><a name="CIT0015" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kabir</span><span class="given-names" tagx="given-names" title="given-names">A. K. M. S.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Matin</span><span class="given-names" tagx="given-names" title="given-names">M. M.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kawsar</span><span class="given-names" tagx="given-names" title="given-names">S. M. A.</span></span></span> (<span class="year" tagx="year" title="year">1998</span>). <span class="mixed-article-title" title="mixed-article-title">Synthesis and antibacterial activities of some uridine derivatives</span>. <span class="source" tagx="source" title="source"><i>The Chittagong University Journal of Science</i></span>, (<span class="issue" tagx="issue" title="issue">1</span>), <span class="fpage" tagx="fpage" title="fpage">13</span>â€"<span class="lpage" tagx="lpage" title="lpage">18</span>.</span></li> <li tag="ref"><a name="CIT0016" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kabir</span><span class="given-names" tagx="given-names" title="given-names">A. K. M. S.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Matin</span><span class="given-names" tagx="given-names" title="given-names">M. M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kawsar</span><span class="given-names" tagx="given-names" title="given-names">S. M. A.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Anwar</span><span class="given-names" tagx="given-names" title="given-names">M. N.</span></span></span> (<span class="year" tagx="year" title="year">1998</span>). <span class="mixed-article-title" title="mixed-article-title">Antibacterial activities of some selectively acylated uridine derivatives</span>. <span class="source" tagx="source" title="source"><i>The Chittagong University Journal of Science</i></span>, (<span class="issue" tagx="issue" title="issue">2</span>), <span class="fpage" tagx="fpage" title="fpage">37</span>â€"<span class="lpage" tagx="lpage" title="lpage">41</span>.</span></li> <li tag="ref"><a name="CIT0017" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kabir</span><span class="given-names" tagx="given-names" title="given-names">A. K. M. S.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Matin</span><span class="given-names" tagx="given-names" title="given-names">M. M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mridha</span><span class="given-names" tagx="given-names" title="given-names">M. A. U.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shahed</span><span class="given-names" tagx="given-names" title="given-names">S. M.</span></span></span> (<span class="year" tagx="year" title="year">1998</span>). <span class="mixed-article-title" title="mixed-article-title">Antifungal activities of some methyl 6-<i>O</i>-trityl-Î±-D-mannopyranosides</span>. <span class="source" tagx="source" title="source"><i>The Chittagong University Journal of Science</i></span>, (<span class="issue" tagx="issue" title="issue">1</span>), <span class="fpage" tagx="fpage" title="fpage">41</span>â€"<span class="lpage" tagx="lpage" title="lpage">46</span>.</span></li> <li tag="ref"><a name="CIT0018" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kabir</span><span class="given-names" tagx="given-names" title="given-names">A. K. M. S.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Matin</span><span class="given-names" tagx="given-names" title="given-names">M. M.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Uddin</span><span class="given-names" tagx="given-names" title="given-names">M. R.</span></span></span> (<span class="year" tagx="year" title="year">1998</span>a). <span class="mixed-article-title" title="mixed-article-title">Comparative studies on selective acylation of uridine using the dibutyltin oxide and direct methods</span>. <span class="source" tagx="source" title="source"><i>The Chittagong University Journal of Science</i></span>, (<span class="issue" tagx="issue" title="issue">1</span>), <span class="fpage" tagx="fpage" title="fpage">97</span>â€"<span class="lpage" tagx="lpage" title="lpage">103</span>.</span></li> <li tag="ref"><a name="CIT0019" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kabir</span><span class="given-names" tagx="given-names" title="given-names">A. K. M. S.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Matin</span><span class="given-names" tagx="given-names" title="given-names">M. M.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Uddin</span><span class="given-names" tagx="given-names" title="given-names">M. R.</span></span></span> (<span class="year" tagx="year" title="year">1998</span>b). <span class="mixed-article-title" title="mixed-article-title">Selective myristoylation and palmitoylation of uridine</span>. <span class="source" tagx="source" title="source"><i>The Chittagong University Journal of Science</i></span>, (<span class="issue" tagx="issue" title="issue">2</span>), <span class="fpage" tagx="fpage" title="fpage">27</span>â€"<span class="lpage" tagx="lpage" title="lpage">35</span>.</span></li> <li tag="ref"><a name="CIT0020" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kruse</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Goerigk</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Grimme</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span> (<span class="year" tagx="year" title="year">2012</span>). <span class="mixed-article-title" title="mixed-article-title">Why the standard B3LYP/6-31G* model chemistry should not be used in DFT calculations of molecular thermochemistry: Understanding and correcting the problem</span>. <span class="source" tagx="source" title="source"><i>The Journal of Organic Chemistry</i></span>, (<span class="issue" tagx="issue" title="issue">23</span>), <span class="fpage" tagx="fpage" title="fpage">10824</span>â€"<span class="lpage" tagx="lpage" title="lpage">10834</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1021/jo302156p">10.1021/jo302156p</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23153035">23153035</a></span></span></li> <li tag="ref"><a name="CIT0021" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lakshmi</span><span class="given-names" tagx="given-names" title="given-names">S. A.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shafreen</span><span class="given-names" tagx="given-names" title="given-names">R. M. B.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Priya</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shunmugiah</span><span class="given-names" tagx="given-names" title="given-names">K. P.</span></span></span> (<span class="year" tagx="year" title="year">2020</span>). <span class="mixed-article-title" title="mixed-article-title">Ethnomedicines of Indian origin for combating COVID-19 infection by hampering the viral replication: Using structure-based drug discovery approach</span>. <span class="source" tagx="source" title="source"><i>Journal of Biomolecular Structure and Dynamics</i></span>. <span class="pub-id"><a href="https://dx.doi.org/10.1080/07391102.2020.1778537">10.1080/07391102.2020.1778537</a></span></span></li> <li tag="ref"><a name="CIT0022" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Laws</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Surani</span><span class="given-names" tagx="given-names" title="given-names">Y. M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hasan</span><span class="given-names" tagx="given-names" title="given-names">M. M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jin</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Al-Adhami</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chowdhury</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Imran</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Psaltis</span><span class="given-names" tagx="given-names" title="given-names">I.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jamshidi</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nahar</span><span class="given-names" tagx="given-names" title="given-names">K. S.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rahman</span><span class="given-names" tagx="given-names" title="given-names">K. M.</span></span></span> (<span class="year" tagx="year" title="year">2020</span>). <span class="mixed-article-title" title="mixed-article-title">Current trends and future approaches in small-molecule therapeutics for COVID-19</span>. <span class="source" tagx="source" title="source"><i>Current Medicinal Chemistry</i></span>, <span class="pub-id"><a href="https://dx.doi.org/10.2174/0929867327666200721161840">10.2174/0929867327666200721161840</a></span></span></li> <li tag="ref"><a name="CIT0023" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lien</span><span class="given-names" tagx="given-names" title="given-names">E. J.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Guo</span><span class="given-names" tagx="given-names" title="given-names">Z.-R.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">R.-L.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Su</span><span class="given-names" tagx="given-names" title="given-names">C.-T.</span></span></span> (<span class="year" tagx="year" title="year">1982</span>). <span class="mixed-article-title" title="mixed-article-title">Use of dipole moment as a parameter in drug-receptor interaction and quantitative structure-activity relationship studies</span>. <span class="source" tagx="source" title="source"><i>Journal of Pharmaceutical Sciences</i></span>, (<span class="issue" tagx="issue" title="issue">6</span>), <span class="fpage" tagx="fpage" title="fpage">641</span>â€"<span class="lpage" tagx="lpage" title="lpage">655</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1002/jps.2600710611">10.1002/jps.2600710611</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/7097526">7097526</a></span></span></li> <li tag="ref"><a name="CIT0024" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lipinski</span><span class="given-names" tagx="given-names" title="given-names">C. A.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lombardo</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dominy</span><span class="given-names" tagx="given-names" title="given-names">B. W.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Feeney</span><span class="given-names" tagx="given-names" title="given-names">P. J.</span></span></span> (<span class="year" tagx="year" title="year">1997</span>). <span class="mixed-article-title" title="mixed-article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span>. <span class="source" tagx="source" title="source"><i>Advanced Drug Delivery Reviews</i></span>, (<span class="issue" tagx="issue" title="issue">1â€"3</span>), <span class="fpage" tagx="fpage" title="fpage">3</span>â€"<span class="lpage" tagx="lpage" title="lpage">25</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1016/S0169-409X">10.1016/S0169-409X</a></span>(96)00423-1<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/10837528">10837528</a></span></span></li> <li tag="ref"><a name="CIT0025" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lucido</span><span class="given-names" tagx="given-names" title="given-names">M. J.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Orlando</span><span class="given-names" tagx="given-names" title="given-names">B. J.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Vecchio</span><span class="given-names" tagx="given-names" title="given-names">A. J.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Malkowski</span><span class="given-names" tagx="given-names" title="given-names">M. G.</span></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Crystal structure of aspirin-acetylated human cyclooxygenase-2: Insight into the formation of products with reversed stereochemistry</span>. <i>Biochemistry</i>, (<span class="issue" tagx="issue" title="issue">8</span>), <span class="fpage" tagx="fpage" title="fpage">1226</span>â€"<span class="lpage" tagx="lpage" title="lpage">1238</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1021/acs.biochem.5b01378">10.1021/acs.biochem.5b01378</a></span></span></li> <li tag="ref"><a name="CIT0026" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Matin</span><span class="given-names" tagx="given-names" title="given-names">M. M.</span></span></span> (<span class="year" tagx="year" title="year">2008</span>). <span class="mixed-article-title" title="mixed-article-title">Synthesis of D-glucose derived oxetane: 1,2-<i>O</i>-isopropylidene-4-(<i>S</i>)-3-<i>O</i>,4-<i>C</i>-methylene-5-<i>O</i>-methanesulfonyl-Î²-L-threo-pento-1,4-furanose</span>. <span class="source" tagx="source" title="source"><i>Journal of Applied Sciences Research</i></span>, (<span class="issue" tagx="issue" title="issue">11</span>), <span class="fpage" tagx="fpage" title="fpage">1478</span>â€"<span class="lpage" tagx="lpage" title="lpage">1482</span>.</span></li> <li tag="ref"><a name="CIT0027" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Matin</span><span class="given-names" tagx="given-names" title="given-names">M. M.</span></span></span> (<span class="year" tagx="year" title="year">2014</span>). <span class="mixed-article-title" title="mixed-article-title">Synthesis and antimicrobial study of some methyl 4-<i>O</i>-palmitoyl-Î±-L-rhamnopyranoside derivatives</span>. <span class="source" tagx="source" title="source"><i>Orbital: The Electronic Journal of Chemistry</i></span>, (<span class="issue" tagx="issue" title="issue">1</span>), <span class="fpage" tagx="fpage" title="fpage">20</span>â€"<span class="lpage" tagx="lpage" title="lpage">28</span>. <span class="pub-id"><a href="https://dx.doi.org/10.17807/orbital.v6i1.553">10.17807/orbital.v6i1.553</a></span></span></li> <li tag="ref"><a name="CIT0028" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Matin</span><span class="given-names" tagx="given-names" title="given-names">M. M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bhattacharjee</span><span class="given-names" tagx="given-names" title="given-names">S. C.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chakraborty</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Alam</span><span class="given-names" tagx="given-names" title="given-names">M. S.</span></span></span> (<span class="year" tagx="year" title="year">2019</span>). <span class="mixed-article-title" title="mixed-article-title">Synthesis, PASS predication, in vitro antimicrobial evaluation and pharmacokinetic study of novel <i>n</i>-octyl glucopyranoside esters</span>. <span class="source" tagx="source" title="source"><i>Carbohydrate Research</i></span>, , <span class="fpage" tagx="fpage" title="fpage">107812</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.carres.2019.107812">10.1016/j.carres.2019.107812</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31585251">31585251</a></span></span></li> <li tag="ref"><a name="CIT0029" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Matin</span><span class="given-names" tagx="given-names" title="given-names">M. M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bhuiyan</span><span class="given-names" tagx="given-names" title="given-names">M. M. H.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Azad</span><span class="given-names" tagx="given-names" title="given-names">A. K. M. S.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Akther</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span></span> (<span class="year" tagx="year" title="year">2017</span>). <span class="mixed-article-title" title="mixed-article-title">Design and synthesis of benzyl 4-<i>O</i>-lauroyl-Î±-L-rhamnopyranoside derivatives as antimicrobial agents</span>. <span class="source" tagx="source" title="source"><i>Current Chemistry Letters</i></span>, (<span class="issue" tagx="issue" title="issue">1</span>), <span class="fpage" tagx="fpage" title="fpage">31</span>â€"<span class="lpage" tagx="lpage" title="lpage">40</span>. <span class="pub-id"><a href="https://dx.doi.org/10.5267/j.ccl.2016.10.001">10.5267/j.ccl.2016.10.001</a></span></span></li> <li tag="ref"><a name="CIT0030" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Matin</span><span class="given-names" tagx="given-names" title="given-names">M. M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bhuiyan</span><span class="given-names" tagx="given-names" title="given-names">M. M. H.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Debnath</span><span class="given-names" tagx="given-names" title="given-names">D. C.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Manchur</span><span class="given-names" tagx="given-names" title="given-names">M. A.</span></span></span> (<span class="year" tagx="year" title="year">2013</span>). <span class="mixed-article-title" title="mixed-article-title">Synthesis and comparative antimicrobial studies of some acylated D-glucofuranose and D-glucopyranose derivatives</span>. <span class="source" tagx="source" title="source"><i>International Journal of Biosciences</i></span>, (<span class="issue" tagx="issue" title="issue">8</span>), <span class="fpage" tagx="fpage" title="fpage">279</span>â€"<span class="lpage" tagx="lpage" title="lpage">287</span>. <span class="pub-id"><a href="https://dx.doi.org/10.12692/ijb/3.8.279-287">10.12692/ijb/3.8.279-287</a></span></span></li> <li tag="ref"><a name="CIT0031" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Matin</span><span class="given-names" tagx="given-names" title="given-names">M. M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bhuiyan</span><span class="given-names" tagx="given-names" title="given-names">M. M. H.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hossain</span><span class="given-names" tagx="given-names" title="given-names">M. M.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Roshid</span><span class="given-names" tagx="given-names" title="given-names">M. H. O.</span></span></span> (<span class="year" tagx="year" title="year">2015</span>). <span class="mixed-article-title" title="mixed-article-title">Synthesis and comparative antibacterial studies of some benzylidene monosaccharide benzoates</span>. <span class="source" tagx="source" title="source"><i>Journal of the Turkish Chemical Society, Section A: Chemistry</i></span>, (<span class="issue" tagx="issue" title="issue">4</span>), <span class="fpage" tagx="fpage" title="fpage">12</span>â€"<span class="lpage" tagx="lpage" title="lpage">21</span>. <span class="pub-id"><a href="https://dx.doi.org/10.18596/jotcsa.83708">10.18596/jotcsa.83708</a></span></span></li> <li tag="ref"><a name="CIT0032" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Matin</span><span class="given-names" tagx="given-names" title="given-names">M. M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bhuiyan</span><span class="given-names" tagx="given-names" title="given-names">M. M. H.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kabir</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sanaullah</span><span class="given-names" tagx="given-names" title="given-names">A. F. M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rahman</span><span class="given-names" tagx="given-names" title="given-names">M. A.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hossain</span><span class="given-names" tagx="given-names" title="given-names">M. E.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Uzzaman</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span> (<span class="year" tagx="year" title="year">2019</span>). <span class="mixed-article-title" title="mixed-article-title">Synthesis, characterization, ADMET, PASS predication, and antimicrobial study of 6-<i>O</i>-lauroyl mannopyranosides</span>. <span class="source" tagx="source" title="source"><i>Journal of Molecular Structure</i></span>, , <span class="fpage" tagx="fpage" title="fpage">189</span>â€"<span class="lpage" tagx="lpage" title="lpage">197</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1016/j.molstruc.2019.05.102">10.1016/j.molstruc.2019.05.102</a></span></span></li> <li tag="ref"><a name="CIT0033" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Matin</span><span class="given-names" tagx="given-names" title="given-names">M. M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chakraborty</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Alam</span><span class="given-names" tagx="given-names" title="given-names">M. S.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Islam</span><span class="given-names" tagx="given-names" title="given-names">M. M.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hanee</span><span class="given-names" tagx="given-names" title="given-names">U.</span></span></span> (<span class="year" tagx="year" title="year">2020</span>). <span class="mixed-article-title" title="mixed-article-title">Novel mannopyranoside esters as sterol 14Î±-demethylase inhibitors: Synthesis, PASS predication, molecular docking, and pharmacokinetic studies</span>. <span class="source" tagx="source" title="source"><i>Carbohydrate Research</i></span>, , <span class="fpage" tagx="fpage" title="fpage">108130</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.carres.2020.108130">10.1016/j.carres.2020.108130</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32863019">32863019</a></span></span></li> <li tag="ref"><a name="CIT0034" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Matin</span><span class="given-names" tagx="given-names" title="given-names">M. M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hasan</span><span class="given-names" tagx="given-names" title="given-names">M. S.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Uzzaman</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bhuiyan</span><span class="given-names" tagx="given-names" title="given-names">M. M. H.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kibria</span><span class="given-names" tagx="given-names" title="given-names">S. M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hossain</span><span class="given-names" tagx="given-names" title="given-names">M. E.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Roshid</span><span class="given-names" tagx="given-names" title="given-names">M. H. O.</span></span></span> (<span class="year" tagx="year" title="year">2020</span>). <span class="mixed-article-title" title="mixed-article-title">Synthesis, spectroscopic characterization, molecular docking, and ADMET studies of mannopyranoside esters as antimicrobial agents</span>. <span class="source" tagx="source" title="source"><i>Journal of Molecular Structure</i></span>, , <span class="fpage" tagx="fpage" title="fpage">128821</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.molstruc.2020.128821">10.1016/j.molstruc.2020.128821</a></span></span></li> <li tag="ref"><a name="CIT0035" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Matin</span><span class="given-names" tagx="given-names" title="given-names">M. M.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ibrahim</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span> (<span class="year" tagx="year" title="year">2010</span>). <span class="mixed-article-title" title="mixed-article-title">Synthesis of some methyl 4-<i>O</i>-octnoyl-Î±-L-rhamnopyranoside derivatives</span>. <span class="source" tagx="source" title="source"><i>Journal of Applied Sciences Research</i></span>, (<span class="issue" tagx="issue" title="issue">10</span>), <span class="fpage" tagx="fpage" title="fpage">1527</span>â€"<span class="lpage" tagx="lpage" title="lpage">1532</span>.</span></li> <li tag="ref"><a name="CIT0036" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Matin</span><span class="given-names" tagx="given-names" title="given-names">M. M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nath</span><span class="given-names" tagx="given-names" title="given-names">A. R.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Saad</span><span class="given-names" tagx="given-names" title="given-names">O.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bhuiyan</span><span class="given-names" tagx="given-names" title="given-names">M. M. H.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kadir</span><span class="given-names" tagx="given-names" title="given-names">F. A. A.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hamid</span><span class="given-names" tagx="given-names" title="given-names">S. B. A.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Alhadi</span><span class="given-names" tagx="given-names" title="given-names">A. A.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ali</span><span class="given-names" tagx="given-names" title="given-names">M. E.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yehye</span><span class="given-names" tagx="given-names" title="given-names">W. A.</span></span></span> (<span class="year" tagx="year" title="year">2016</span>). <span class="mixed-article-title" title="mixed-article-title">Synthesis, PASS-predication and in vitro antimicrobial activity of benzyl 4-<i>O</i>-benzoyl-Î±-L-rhamnopyranoside derivatives</span>. <span class="source" tagx="source" title="source"><i>International Journal of Molecular Sciences</i></span>, (<span class="issue" tagx="issue" title="issue">9</span>), <span class="fpage" tagx="fpage" title="fpage">1412</span><span class="pub-id"><a href="https://dx.doi.org/10.3390/ijms17091412">10.3390/ijms17091412</a></span></span></li> <li tag="ref"><a name="CIT0037" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Matin</span><span class="given-names" tagx="given-names" title="given-names">M. M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Roshid</span><span class="given-names" tagx="given-names" title="given-names">M. H. O.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bhattacharjee</span><span class="given-names" tagx="given-names" title="given-names">S. C.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Azad</span><span class="given-names" tagx="given-names" title="given-names">A. K. M. S.</span></span></span> (<span class="year" tagx="year" title="year">2020</span>). <span class="mixed-article-title" title="mixed-article-title">PASS Predication, antiviral, <i>in vitro</i> antimicrobial, and ADMET studies of rhamnopyranoside esters</span>. <span class="source" tagx="source" title="source"><i>Medical Research Archives</i></span>, (<span class="issue" tagx="issue" title="issue">7</span>), <span class="fpage" tagx="fpage" title="fpage">2165</span><span class="pub-id"><a href="https://dx.doi.org/10.18103/mra.v8i7.2165">10.18103/mra.v8i7.2165</a></span></span></li> <li tag="ref"><a name="CIT0038" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">McLaughlin</span><span class="given-names" tagx="given-names" title="given-names">J. L.</span></span></span> (<span class="year" tagx="year" title="year">1991</span>). Crown-gall tumours in potato discs and brine shrimp lethality: Two simple bioassays for higher plant screening and fractionation. In <span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hostettmann</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span></span> (Ed.), <span class="source" tagx="source" title="source"><i>Methods in plant biochemistry: Assays for bioactivity</i></span> (Vol. <span class="volume" tagx="volume" title="volume">6</span>, pp. 1-32). <span class="publisher-name" tagx="publisher-name" title="publisher-name">Academic Press</span>.</span></li> <li tag="ref"><a name="CIT0039" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pearson</span><span class="given-names" tagx="given-names" title="given-names">R. G.</span></span></span> (<span class="year" tagx="year" title="year">1986</span>). <span class="mixed-article-title" title="mixed-article-title">Absolute electronegativity and hardness correlated with molecular orbital theory</span>. <span class="source" tagx="source" title="source"><i>Proceedings of the National Academy of Sciences of the United States of America</i></span>, (<span class="issue" tagx="issue" title="issue">22</span>), <span class="fpage" tagx="fpage" title="fpage">8440</span>â€"<span class="lpage" tagx="lpage" title="lpage">8441</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1073/pnas.83.22.8440">10.1073/pnas.83.22.8440</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16578791">16578791</a></span></span></li> <li tag="ref"><a name="CIT0040" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pires</span><span class="given-names" tagx="given-names" title="given-names">D. E. V.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Blundell</span><span class="given-names" tagx="given-names" title="given-names">T. L.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ascher</span><span class="given-names" tagx="given-names" title="given-names">D. B.</span></span></span> (<span class="year" tagx="year" title="year">2015</span>). <span class="mixed-article-title" title="mixed-article-title">pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures</span>. <span class="source" tagx="source" title="source"><i>Journal of Medicinal Chemistry</i></span>, (<span class="issue" tagx="issue" title="issue">9</span>), <span class="fpage" tagx="fpage" title="fpage">4066</span>â€"<span class="lpage" tagx="lpage" title="lpage">4072</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1021/acs.jmedchem.5b00104">10.1021/acs.jmedchem.5b00104</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25860834">25860834</a></span></span></li> <li tag="ref"><a name="CIT0041" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sharavanan</span><span class="given-names" tagx="given-names" title="given-names">V. J.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sivaramakrishnan</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sivarajasekar</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Senthilrani</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kothandan</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dhakal</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sivamani</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Show</span><span class="given-names" tagx="given-names" title="given-names">P. L.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Awual</span><span class="given-names" tagx="given-names" title="given-names">M. R.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Naushad</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span> (<span class="year" tagx="year" title="year">2020</span>). <span class="mixed-article-title" title="mixed-article-title">Pollutants inducing epigenetic changes and diseases</span>. <span class="source" tagx="source" title="source"><i>Environmental Chemistry Letters</i></span>, (<span class="issue" tagx="issue" title="issue">2</span>), <span class="fpage" tagx="fpage" title="fpage">325</span>â€"<span class="lpage" tagx="lpage" title="lpage">343</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1007/s10311-019-00944-3">10.1007/s10311-019-00944-3</a></span></span></li> <li tag="ref"><a name="CIT0042" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Siegel</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hui</span><span class="given-names" tagx="given-names" title="given-names">H. C.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Doerffler</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Clarke</span><span class="given-names" tagx="given-names" title="given-names">M. O.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chun</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Neville</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Carra</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lew</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ross</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">Q.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wolfe</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jordan</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Soloveva</span><span class="given-names" tagx="given-names" title="given-names">V.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Knox</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Perry</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Perron</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Stray</span><span class="given-names" tagx="given-names" title="given-names">K. M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Barauskas</span><span class="given-names" tagx="given-names" title="given-names">O.</span></span>, â€¦ <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mackman</span><span class="given-names" tagx="given-names" title="given-names">R. L.</span></span></span> (<span class="year" tagx="year" title="year">2017</span>). <span class="mixed-article-title" title="mixed-article-title">Discovery and synthesis of a phosphoramidate prodrug of a Pyrrolo[2,1-f][triazin-4-amino] adenine C-nucleoside (GS-5734) for the treatment of ebola and emerging viruses</span>. <span class="source" tagx="source" title="source"><i>Journal of Medicinal Chemistry</i></span>, (<span class="issue" tagx="issue" title="issue">5</span>), <span class="fpage" tagx="fpage" title="fpage">1648</span>â€"<span class="lpage" tagx="lpage" title="lpage">1661</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1021/acs.jmedchem.6b01594">10.1021/acs.jmedchem.6b01594</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28124907">28124907</a></span></span></li> <li tag="ref"><a name="CIT0043" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Strasser</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Maier</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Leisser</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Saiko</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Madlener</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bader</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bernhaus</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gueorguieva</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Richter</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mader</span><span class="given-names" tagx="given-names" title="given-names">R. M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wesierska-Gadek</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Schott</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Szekeres</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fritzer-Szekeres</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Krupitza</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span></span> (<span class="year" tagx="year" title="year">2006</span>). <span class="mixed-article-title" title="mixed-article-title">5-FdUrd-araC heterodinucleoside re-establishes sensitivity in 5-FdUrd- and AraC-resistant MCF-7 breast cancer cells overexpressing ErbB2</span>. <span class="source" tagx="source" title="source"><i>Differentiation; Research in Biological Diversity</i></span>, (<span class="issue" tagx="issue" title="issue">9â€"10</span>), <span class="fpage" tagx="fpage" title="fpage">488</span>â€"<span class="lpage" tagx="lpage" title="lpage">498</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1111/j.1432-0436.2006.00082.x">10.1111/j.1432-0436.2006.00082.x</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17177846">17177846</a></span></span></li> <li tag="ref"><a name="CIT0044" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Susilo</span><span class="given-names" tagx="given-names" title="given-names">R. (KÃ¶ln, DE).</span></span></span> (<span class="year" tagx="year" title="year">2008</span>). Pharmaceutically active uridine esters, United States, Trommsdorff GmbH &amp;amp; Co. KG Arzeneimittel (Alsdorf, DE) 7417034. <a href="http://www.freepatentsonline.com/7417034.html">http://www.freepatentsonline.com/7417034.html</a></span></li> <li tag="ref"><a name="CIT0045" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wahedi</span><span class="given-names" tagx="given-names" title="given-names">H. M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ahmad</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Abbasi</span><span class="given-names" tagx="given-names" title="given-names">S. W.</span></span></span> (<span class="year" tagx="year" title="year">2020</span>). <span class="mixed-article-title" title="mixed-article-title">Stilbene-based natural compounds as promising drug candidates against COVID-19</span>. <span class="source" tagx="source" title="source"><i>Journal of Biomolecular Structure and Dynamics</i></span>. <span class="pub-id"><a href="https://dx.doi.org/10.1080/07391102.2020.1762743">10.1080/07391102.2020.1762743</a></span></span></li> <li tag="ref"><a name="CIT0046" /><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yamamoto</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Koyama</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kurajoh</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shoji</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tsutsumi</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span>, &amp;amp; <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Moriwaki</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span></span> (<span class="year" tagx="year" title="year">2011</span>). <span class="mixed-article-title" title="mixed-article-title">Biochemistry of uridine in plasma</span>. <span class="source" tagx="source" title="source"><i>Clinica Chimica Acta; International Journal of Clinical Chemistry</i></span>, (<span class="issue" tagx="issue" title="issue">19â€"20</span>), <span class="fpage" tagx="fpage" title="fpage">1712</span>â€"<span class="lpage" tagx="lpage" title="lpage">1724</span>. <span class="pub-id"><a href="https://dx.doi.org/10.1016/j.cca.2011.06.006">10.1016/j.cca.2011.06.006</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21689643">21689643</a></span></span></li> </ul> </div> </div>  </body></html>